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ABSTRACT 
 
 
 Towards the goal of improving the knowledge base of how drugs of abuse 
function to create addicts and using currently uninvestigated areas of this knowledge 
base, we focused our research studies the male albino rat, and strived to explain how 
cocaine sensitization alters particular molecular mechanisms in the mesocorticolimbic 
system related to glutamate receptors, SAPAPs, and affects drug self-administration. 
Taking all the previously discussed research studies into consideration, we hypothesized 
that low-dose cocaine self-administration would yield a significant elevation in drug 
seeking behavior for psychostimulant sensitized animals. For specific changes at the 
PSD, we hypothesized that acute cocaine exposure and/or cocaine sensitization would 
alter iGluRs levels in the mPFC, and SAPAP levels in multiple sites of the 
mesocorticolimbic system. To test these hypotheses, we investigated the effects of 
psychostimulant sensitization on various parameters of self-administration by infusing a 
low-dose cocaine reward proven to not induce sensitization during self-administration 
(reported here as 0.3 mg/kg/infusion). Although drug exposure did not significantly alter 
self-administration behavior, we did find that more drug exposed subjects acquired self-
administration behavior when compared to drug naïve controls. We also investigated the 
effects of acute cocaine exposure and/or cocaine sensitization on iGluRs in the mPFC and 
SAPAPs in the entire mesocorticolimbic circuit thru western blotting, immunolabeling of 
proteins of interest, and comparing protein levels to those found in cocaine naïve 
controls. A limited self-administration protocol also tested if SAPAP levels were altered 
by self-administration of a low-dose cocaine reward. For these experiments, we found 
that SAPAP protein levels are altered in multiple regions of the mesocorticolimbic 
system in response to contingent and non-contingent cocaine exposure, and that iGluR 
receptor subunits are altered in the prefrontal cortex in response to non-contingent 
cocaine exposure. 
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PREFACE 
 
 
The Incans that first cultivated the coca plant for medicinal use five millennia ago 
reserved this “Elixir of the Gods” for priests, social elites and ‘pure’ virgin sacrifices. In 
more modern times, cocaine has even been believed to be the cure to cancer and called 
the “champagne of drugs”. Yet today, cocaine use (especially in the crystallized free-base 
form of “crack”) is associated with the dregs of society. As the complexities (and the 
associated evils) of our modern society increases, so seems the prevalence of addictions 
of all varieties.  
 
Cocaine addiction is defined as a long-lasting disorder marked by chronic and 
compulsive cocaine use, resulting in neurobiological changes. Behavioral, these changes 
are characterized by a loss of control over use, eventual tolerance, and social isolation. If 
untreated, death from some facet of drug use usually occurs. Unfortunately, very few 
treatments options exist, and even fewer with high rates of success. Currently, none of 
these more successful treatments options include targeted pharmacological therapy. In an 
effort to rectify this, the development and research of treatment options are a priority for 
pharmaceutical companies and are constantly evolving. Although especially prevalent in 
the United States, cocaine addiction has reached epidemic levels worldwide. Cocaine 
addiction does not discriminate by social class: addicts range from those in poor inner-
city communities, to those working on Wall Street. This widespread use is possibly 
because of social factors that foster maladaptive behaviors, and possibly even 
environmental contamination resulting from inappropriately discarded industrial waste.  
 
The effects of cocaine addiction are not restricted to biological factors, or even 
solely to cocaine users. It is a fact (although one that may not fit the widely accepted 
narrative) that most cocaine users only use recreationally, and do not develop an 
addiction. As of 2008, the National Institute on Drug Abuse (NIDA) reported that 
approximately 16 million people between the ages of 15 and 64 years worldwide had 
used cocaine at some point in their lives. Roughly half of this number (7.1 million) is 
represented by North Americans. Yet, this same year, it was reported that only 1.4 
million people (~3% of Americans) met the clinical requirements under DSM-IV to be 
diagnosed as having a dependence on/ an addiction to cocaine. Among this minority who 
transition from recreational use to addiction, compulsivity accompanies drug use. These 
compulsive features of addiction include a perceived lack of control over drug use, and 
continued use despite negative consequences associated with addiction. These 
compulsive symptoms may be related to the impairment of executive function in drug 
users, as addicts who are diagnosed with high levels of compulsivity also are less likely 
to persevere in accomplishing long term goals. This same study also found that 
impulsivity also was likely associated with cocaine use, as addicts made decisions with 
less forethought. A compulsivity surrounding drug use is also suggested by the finding 
that cocaine addicts prefer to use drugs in one specific place. This culmination of 
enhanced compulsivity and impulsivity in cocaine addicts may also become expressed in 
ways not associated with drug use, as cocaine addicts tends to crave foods with more fat 
and carbohydrates than the general public.  
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These few who make drug use an all-encompassing lifestyle are a substantial 
percentage of mentally ill drug users, those with emergency hospital admissions, and 
criminal arrestees. In fact, cocaine intoxication among arrestees is a significant problem 
according to The Office of National Drug Control Policy. In its annual Arrestee Drug 
Abuse Monitoring Program (ADAM) II Report, the Office of National Drug Control 
Policy reports that 19% of arrestees in Chicago (25% in New York City) were under the 
influence of cocaine at the time of their arrest in 2012. These arrestees can present a job 
hazard to law enforcement officers by exhibiting hyper-aggressive behavior. This 
behavior may indicate an underlying medical disorder caused by prolonged cocaine use 
known as Excited Delirium (more commonly, “cocaine psychosis”). Cocaine psychosis is 
a collection of symptoms that manifests with delirium, anxiety, hallucinations, 
psychomotor agitation, elevated temperature/heart rate, and superhuman 
strength/resistant to pain. Fatal cocaine overdose is commonly preceded by cocaine 
psychosis, and occurs most commonly due to respiratory paralysis.  
 
Interest from law enforcement extends beyond the scope of individual users to 
those profiting most from the cocaine economy; the sellers. Although seizures of illicit 
cocaine imports to US has fallen in recent years, demand for the substance and associated 
crimes have not. This phenomenon is likely not due to crimes-of-opportunity committed 
by a large group of people, but the intense motivation of small numbers. Consider the 
example of burglary in a residential neighborhood. According to the Memphis Police 
Department, when there is a “rash” of home robberies in a neighborhood, many times 
these crimes completely stop for the area after a single perpetrator is apprehended. This is 
because usually instead of many people committing small fractions of the crime, there 
was one person committing them all. Ironically, cocaine use and property crimes are 
strongly correlated. 
 
With this example in mind, it is no surprise that the architects in this illicit drug 
trade also consist of a relatively small number of people. The plant from which cocaine is 
extracted, Erythroxylon coca, is native to and grows solely at high elevations in the 
relatively poor countries of Bolivia, Columbia, and Peru. This gives any traffickers of 
cocaine in these regions a virtual monopoly on sales due to the fact that cocaine is 
traditionally much easier to extract from the plant itself than to synthetically produce. 
Moreover, the United States is the most lucrative market for vendors, geographically 
close to these regions, and has multiple routes for smugglers to exploit due its 
expansive/largely unrestricted border. Sales in the United States also provides a high 
return on initial investment due to the wealth of the American consumer when compared 
to those in many of the surrounding countries. This is evidenced by the fact that as of 
2014, a single “uncut” kilogram of cocaine in America can sell for an average of $30,500. 
This is price is verified by local law enforcement in Memphis, Tennessee, as the same 
kilogram can be sold locally for anywhere between $25,000 and $31,000. In Bolivia, the 
same kilogram can be purchased for $800 to $1,500 which translates to at least a hefty 
1,600% return on the initial investment.  
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This black market economy is so pervasive and successful that the website for the 
iconic business publication The Economist devoted an entire section to the economic 
aspects of cocaine use and trafficking. It is befitting that this publication is interested in 
cocaine, because not only are high levels of cocaine commonly found on our paper 
currency, but because this cocaine economy has attracted the attention of world 
governments and organizations. For example, the United States spends upwards of $35 
billion annually on drug control efforts. In a global targeted response, a UN taskforce has 
been dedicated to the eradication of the drug trade, and the violent efforts of criminals to 
monopolize its production and sale. Cross-border cooperation efforts are also coordinated 
between governments (i.e. Mexico and the United States) to incapacitate “cartels” 
responsible for cocaine production. This cooperation includes kinetic action operations 
and the seizure of cartel assets on both sides of the border. Two factors that must be 
examined to understand the motivations of any organization (legal or illicit) is ease of 
access to raw materials, and the risk/reward ratio. Considering that the qualities that 
cocaine imparts can become quite tempting to users, any rewards are greater than risks to 
importers. 
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CHAPTER 1.    INTRODUCTION 
 
 
Cocaine Addiction and Sensitization 
 
Cocaine users report that cocaine imparts a feeling of euphoria, as well as 
increased endurance, stamina, and resistance to fatigue. Indeed, these qualities are 
virtually verbatim extolled by Sigmund Freud, who prescribed it to his patients and 
struggled with cocaine dependence personally [1]. In his 1884 manuscript in support of 
cocaine, Über Coca, he described the substance as “[inducing] the most gorgeous 
excitement….. [warding] off hunger, sleep, fatigue, and steels one to intellectual effort” 
[2]. Despite Freud’s support earlier in his career, cocaine use can be dangerous. 
Interestingly, not only is this alkaloid a naturally occurring neurotoxic pesticide [3], but 
also has a high addiction potential.  
 
Death from cocaine overdose can often be disturbing to observe [4, 5]. Scientists 
strive to explain why addicts willingly use cocaine, with possible psychological 
explanations including modeling cocaine use as a learned behavior that serves as an 
‘escape hatch’ to the prevention of/solution to emotional distress [6]. Another theory 
posits that small minority of users that become addicted may be experiencing a perfect 
storm of drug exposure, social reinforcement, environmental priming [7] and genetic 
predisposition [8]. Additional studies even indicate that those who have lost all perceived 
control over their drug use usually report chronic stress/ abuse during their childhoods 
and adolescences [9]. While not necessarily directly responsible for their drug use, these 
events may act as precipitating factors. As evidence in animal models, juvenile rats 
display behavior reminiscent of cocaine sensitization upon their initial exposure to 
cocaine if exposed to repeated, intermittent, and uncontrollable foot shocks. In this 
“stress sensitization” theory, stress acts a causative agent in the sensitization process in 
place of cocaine. Similarly, both agents require repeated, intermittent exposure and 
activate the HPA axis-centered stress response ([10], review). While this manuscript does 
not discount these factors, our research group also contends that the early effects of 
cocaine itself may contribute equally, if not more, to the development of cocaine 
dependence. The initial effects of cocaine use, while reported to be pleasurable, may also 
result in cocaine sensitization. Cocaine sensitization is defined as the ability of repeated 
exposure to psychostimulants, such as cocaine or amphetamine, to result in lifelong drug-
induced neurophysiologic modifications. The hallmark of sensitization is the ability of a 
specific dose of a psychostimulant to elicit higher locomotor responses upon repeated 
administration [11].  
 
Behavioral expression of cocaine sensitization is caused by distinct molecular and 
anatomical modifications due to long term drug exposure. Cocaine sensitization is also 
believed to be responsible for socially-disturbing aspects of addiction, including the 
cocaine-induced psychosis and its associated risks, relapse despite years of abstinence, 
and intrusive thoughts of drugs/drug use. Although traditionally associated with animal 
studies, there is evidence that sensitization occurs in humans, resulting in similar 
behavioral and molecular consequences. Although not well understood, this phenomenon 
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is not new to the scientific world; the earliest reports of psychosis can be dated to the late 
19th century [12]. In fact, the Incans also reported that the effects of cocaine increase 
over days of use, a phenomena that researchers at the time described as “increase in 
reflex excitability” paired with increased “gayness” [13]. Sensitization, by the nature of 
the phenomenon, is practically impossible to observe in human addicts, and has long 
been a topic on controversy among researchers of addiction [14].  
 
The crux of the argument against cocaine sensitization stems from the difficulty 
of observing its development in humans. Direct observation is virtually impossible since 
it would occur very early in the addiction process before addicts would usually seek 
professional help to control their addiction. In addition to the aforementioned historical 
anecdotes, there are however very compelling studies that suggest its existence in 
humans. For example, the repeated and intermittent doses of a stimulant that acts through 
similar mechanisms as cocaine (methamphetamine) increases the eye blink, heart rate, 
and subjective feeling of euphoria in drug naïve volunteers [15, 16]. Cocaine addicts also 
tend to display repetitive and seemingly non-productive movement patterns, which is 
similar to stereotypy observed in sensitized rats after repeated exposure to drug [17-19].  
 
Yet, no matter how debilitating and immense the challenges against current drug 
users, it could be argued that the most insurmountable challenges begin after use ends. 
One of the most challenging aspects of addiction is the phenomenon of relapse, which 
can occur after months or even years of complete drug abstinence. Addicts in relapse 
often cite a wide variety of common world objects eliciting a strong and seemingly 
uncontrollable craving [20] (i.e. walking past a bar if an alcoholic). Based on these 
reports from addicts, relapse behavior is also commonly studied in rodent models as cue 
induced reinstatement. Rats exposed intermittently to cocaine can be trained to self-
administer drug in conjunction with a cue light activated when cocaine is administered. 
When extinguished, rats will reinstate their drug-seeking behavior when presented with a 
cue light, often after long periods of forced abstinence [21].  
 
Sensitization changes on a smaller scale in model organisms are responsible for 
the maintenance of operant responding for drug [22], and consist of neuronal changes at 
the molecular [23] and anatomical [24] level. Even though many of the molecular events 
leading up to, and that occur during sensitization are poorly understood, it is seemingly 
permanent. As evidence, these changes persist even after a full year of abstinence in 
response to a systemic challenge dose in rodent models [25]. This is a significant time 
period considering rats rarely live this long in the wild, and typically live approximately 2 
years under laboratory conditions [26]. Sensitization almost certainly plays a role in the 
maintenance of self-administration, although few self-administration studies have 
examined the direct effects of sensitization on drug acquisition. There have not been any 
published studies that proposed a model using a dose high enough to stimulate an animal 
to respond, yet low enough to avoid inadvertent sensitization of saline controls.  
 
When examining addiction using the earlier outlined features of cocaine 
addiction, certain facets of this disease could be considered subjective. For example, how 
much loss of control over use must be observed to qualify for addiction? Exactly what 
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defines social isolation? Although the exact scale of these features may vary 
qualitatively, the neurobiological changes can be defined in a clear quantitative manner. 
Although important to a global understanding, in this manuscript we limit our discussion 
of addiction to the neurobiological plasticity caused by cocaine exposure. On this front, a 
wealth of human data indirectly implicates various neurotransmitter systems in response 
to chronic cocaine exposure. Yet, animal models are arguably a more useful tool in 
dissecting the exact molecular, anatomical, and physiological effects caused by cocaine 
exposure. Our model organism of choice is the rat, considering the relatively low cost of 
maintenance, small storage footprint, the ability to conduct invasive procedures 
impossible in human beings, and the fact that the rat model has a long history of use in 
addiction studies, and will respond for cocaine under operant training [27].  
 
 
Animal Models of Addiction 
 
The Science of Making Drug Addicted Animals by S.H. Ahmed [7] goes into 
great detail about the social and neurological factors that may lead to drug abuse, and 
how these factors can be reliably reproduced in rats. Concentrating this work to its most 
basic levels, we uncover several important themes. Similar to clinical literature, animal 
studies involving rats prove that many animals show resilience against cocaine acquiring 
self-administration. As evidence, most rats have a strong preference to saccharin-fortified 
“sweet water” over a cocaine reinforcer even following extended access to cocaine. Yet if 
lacking an alternative choice under self-administration, almost all animals will respond 
for a cocaine reward in an operant chamber [7]. However, when given the choice to either 
respond for sweet water or cocaine, very few animals continue to prefer drug rewards. 
Indeed, out of 184 rats examined using self-administration studies over 5 years, only 16 
animals (termed ‘high responders’) prefer cocaine over the sweetened water. This result 
is not due to saccharin aversion, since when given access to sweet water alone, these rats 
consumed similar amounts to non-cocaine preferring rats [7].  
 
Parallel to clinical studies, an escalation of drug use is observed in rats given 
extended access to drug. These same animals also show increased motivation to self-
administer cocaine. As evidence, extended access to cocaine is associated with increased 
break points under progressive ratio (PR) testing, higher break points over control 
animals with sham infusions, and higher break points during self-administration with a 
cue previously associated with pain. Additionally, rats will continue to self-administer 
cocaine even when deprived of food and given a choice of hunger-abating water with 
sucrose added, a result that the author attributes to the compulsive nature of runaway 
drug use [7]. Drug preferring animals and humans also both display parallel systemic 
effects of cocaine, especially in relation to its effects on cardiac function and stress-
priming. These topics are beyond the scope of this text, and are treated in through detail 
in other published manuscripts [28-31].  
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Dopamine 
 
However, experiments in animal models have shown that cocaine acts through a 
fairly simple mechanism of action of monoamine reuptake inhibition. This subject is well 
within our scope, especially since this mechanism precipitates cocaine sensitization. 
Cocaine induced changes in monoamine levels are caused by cocaine’s targeting of 
monoamine transporters [32]. These transporters are responsible for removing 
neurotransmitters from the synaptic cleft after presynaptic release [33], and are 
responsible for the most common effects of the drug when inhibited by cocaine [34]. 
While cocaine blocks all monoamine transporters to some degree [35, 36], its main action 
responsible for the reinforcing properties of cocaine is blockade of the dopaminergic 
transporter (DAT) [37-39]. As evidence, animals trained to self-administer cocaine will 
self-administer the specific DAT inhibitor PTT at similar levels to cocaine [40]. This 
DAT blockade, while pan-neuronal in nature, differentially affects discrete regions of the 
mesocorticolimbic system in the sensitized brain [11, 41]. Although increased locomotion 
is the main phenotypic expression of sensitization, this motor effect “saturates” in 
contrast to the perceived reinforcing effects of cocaine which continue to escalate as 
exposure increases [42]. This escalation may be the main motivator that drives addiction.   
 
Sensitization can be modeled by two distinct phases that involve the ventral 
tegmental area (VTA) in the midbrain, and the nucleus accumbens (Nacc) and medial 
prefrontal cortex (mPFC) in the forebrain (Figure 1-1). The first is associated with the 
VTA, which precipitates secondary phase in the Nacc. This first VTA-centered phase can 
be described as initiation (or incubation), during which cocaine exposure directly causes 
an increase in synaptic dopamine by DAT blockade, which in turn causes immediate 
transient effects.  During incubation, while cocaine induces intense feeling of euphoria, 
the behavioral hallmarks of sensitizations are not present. As DAT blockade-induced 
molecular events began developing, output from the VTA to the Nacc is altered. As 
evidence for this incubation theory, blocking all protein synthesis in VTA can completely 
block the behavioral effects of sensitization [43]. Moreover, this study also found 
intracranial injections of cocaine directly in to the VTA but not the Nacc of drug naïve 
rats leads to behavioral sensitization along with its molecular hallmarks in the Nacc. 
Through altered input from the VTA in the initiation phase by dopaminergic “A10” 
neurons to the Nacc, the secondary phase of sensitization develops [44]. During 
expression, increased output from medium spiny neurons in the Nacc to the motor cortex 
results in enhanced motor responses. It is important to note that this process of expression 
is delayed when compared to the immediate effects of initiation. Considering 
neurotransmitters systems act in concert to regulate behavior, increases in dopamine in a 
discrete area such as the VTA has far reaching implication to a wide variety of brains 
areas and neurotransmitter systems [45]. In this manuscript, we will focus on how 
glutamate transmission is altered in the mPFC by cocaine exposure.  
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Figure 1-1. Diagram of Sensitization Related Areas in the Rat Brain.  
Diagram of the location of key brain areas involved in sensitization and neurotransmitter 
projections. Dopamine originates in the VTA and projecting to the Nacc and mPFC. 
Glutamate originates in the mPFC and projects to the Nacc and VTA. Reprinted from 
Brain Research Reviews, volume 41/issue 2-3, Jeffrey D Steketee, “Neurotransmitter 
systems of the medial prefrontal cortex: potential role in sensitization to 
psychostimulants”, Pages No. 203-228, 2003, with permission from Elsevier [46]. 
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Glutamate 
 
The prefrontal cortex is heavily modified by drug use, and is the source of 
glutamate to other regions of the mesocorticolimbic circuit. In vitro application of 
dopamine transiently depresses prefrontal glutamatergic synaptic responses in cocaine 
naïve rats, which is extended when paired with tetanic stimulation [47]. Additionally, 
cocaine increases extracellular dopamine levels in the prefrontal cortex of acutely 
exposed animals [48]. After 7 days of cocaine abstinence, markers of reduced synaptic 
activity are observed including reduced prefrontal dendrite density and spine number 
[49]. These findings suggest that increase dopamine levels observed due to early cocaine 
exposure causes suppression of synaptic activity in the prefrontal cortex at later time 
points. This effect may be evidenced in addicts by the fact that live addicts show 
functional “lesions” in fMRI scans in the prefrontal cortex [50]. Furthermore, prefrontal 
cortical lesions have been shown to affect inhibitory dopaminergic D2 receptors in the 
Nacc [51] which may have functional consequences for relapse behavior [52]. As a 
result, current literature implicates glutamate as occupying an increasingly more 
important role in the processes of drug-induced euphoria, psychosis, craving, and relapse. 
This also links glutamate to cocaine-induced behavioral changes. In addition, specific 
prefrontal areas such as the anterior cingulate gyrus and the lateral prefrontal cortex show 
reduced function in abstinent cocaine abusers that is negatively correlated with increased 
cocaine exposure. This is an important finding, as the connection between these two areas 
is associated with making decisions involving intense mental effort and choosing an 
atypical response (drug abstinence) over a habitual one (continued drug abuse) [53].  
 
In addition to hypofunctional areas in the medial prefrontal cortex (mPFC) and 
morphology changes in individual neurons, cocaine exposure causes changes on a 
smaller-scale affecting receptor population and receptor function. These changes are 
well-documented in animals exposed to cocaine in other regions of the mesocorticolimbic 
system. Yet, while prefrontal glutamate is a clear mediator of cocaine-induced behavior, 
any effects of cocaine sensitization on ionotropic glutamate receptors (iGluRs) have yet 
to be examined in the prefrontal cortex. These ionic receptors are the main mediators of 
glutamatergic effects in the adult brain, and are split between two main classes of 
receptors, consisting of multiunit complexes that join together to form a membrane-
spanning cation-permeable pore (Figure 1-2). Examined for selective agonism, iGluRs 
are sensitive to either α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
or to N-methyl-D-aspartic acid (NMDA). This preference is determined by the spacing 
between the amino and carboxylate groups of each subunit [54].  
 
The effects that are responsible for glutamate being the main excitatory 
neurotransmitter in the brain are mediated by ionotropic AMPA-sensitive [55] glutamate 
receptors, and are often referred to as “excitatory glutamate receptors” in older literature 
as a reflection of this fact [56, 57]. Structurally, these receptors consist of four pore-
forming subunits of two subunits types, a configuration that could be envisioned as a 
dimer (heterotetramer) of dimers (2 identical subunits of only GluR1/2/3or 4) [58]. When 
fully assembled, these receptor serve as major mediators of long-term potentiation, as  
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Figure 1-2. General Structure of iGluRs and mGluRs.  
While iGluRs are assembled from several subunits to form a membrane-spanning pore 
permeable to cations, mGluRs activate signal cascades in response to glutamate. Note 
that mGluRs can also regulate iGluRs.  Reprinted with permission from Webvision. 
Connaughton, V., Glutamate and Glutamate Receptors in the Vertebrate Retina., in 
Webvision: The Organization of the Retina and Visual System [Internet], F.E. Kolb H, 
Nelson R, Editor 2005 May 1 [Updated 2007 May 7], University of Utah Health Sciences 
Center: Salt Lak City, UT. [59]. 
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high frequency stimulation of neurons can result in synaptic strengthening through 
increasing the ratio of AMPARs to NMDARs [60].  
 
Along with AMPA receptors, NMDA-type glutamate receptors are vital to any 
discussion of the effects of cocaine exposure. These receptors are key players in the 
functions of synaptic plasticity and enduring changes in cortical neurons [61]. Low-level 
stimulation of NMDA receptors leads to synaptic depression (weakening) [62], higher 
stimulation leads to synaptic potentiation (strengthening) [63], and very high levels leads 
to cell death [64], all of which are processes dependent on Ca2+ influx. Similar to  
AMPA-type glutamate receptors, NMDA receptors are voltage-gated, responsive to L-
glutamate [65], PSD localized [66], and consist of heterotetrameric units [67]. Mature 
NMDA receptors contain a constitutive and ubiquitously expressed NR1 subunit and at 
least one member of the NR2 subunit family (NR2A/B/C/D) confined to more discrete 
areas [68].  
 
Although not examined in the prefrontal cortex, iGluR populations are mis-
regulated in the remainder of the mesocorticolimbic circuit in response to cocaine 
sensitization. These effects include transient changes in the VTA that increases dopamine 
output to the Nacc through enhancement of AMPA receptor currents [69]. In contrast to 
those in the VTA, sensitization-induced changes in the Nacc appear to be permanent and 
alter glutamate receptor population and function. These changes in the Nacc cause a 
regional hyper-excitability due to an increased contribution of Ca2+-permeable AMPA 
receptors, but also a decrease in any glutamatergic braking ability by mGlur1 and NMDA 
receptor input. Considering that the NMDAR subunits NR2A/B are expressed at their 
highest levels in the cerebral cortex [70], it stands to reason that changes in iGlurR 
population due to sensitization should be thoroughly investigated in the mPFC. 
Surprisingly, any prefrontal iGluR population changes in response to cocaine 
sensitization have yet to be published. Additionally, clinical studies have shown 
decreased overall activity and glutamate levels in the prefrontal cortex of cocaine addicts 
even after abstinence [71]. This indicates that prefrontal glutamate receptors could play a 
vital role in the long term expression of sensitization.  
 
Considering the braking ability of mGluRs cited above, mechanisms affecting the 
expression of cocaine sensitization appear to include ionic receptor changes as well as 
intracellular signaling cascades. In addition to their functions of current conduction and 
similar to mGluRs, iGluRs have the ability to initiate cell signaling through their 
intracellular domains to regulate synaptic responses. As evidence, NMDA receptors 
regulate the surface expression of AMPA receptors through the Ras-ERK pathway, with 
NR2A-containing NMDARs promoting AMPAR expression, and those containing NR2B 
subunits depressing this expression [72]. AMPA receptors even have the ability to 
remove themselves from the synapse via the GluR2 subunits through BRAG2-mediated 
endocytosis [73]. These signaling mechanisms, however, may not only regulate the 
functional ratio of AMPA/NMDA receptors at the synapse, but could also alter function 
of receptors present at the synapse. Phosphorylation by PKC of the GluR1 subunit at 
Ser(831) increases AMPA channel conductance [74]. In addition to these phenomena, 
cytoskeletal remodeling is known facilitate drug-induced habit formation in an unknown 
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fashion [75], and in the case of cocaine sensitization, clear and dramatic morphological 
changes occur in MSNs of the Nacc [76]. Synapse associated proteins may participate is 
this process, and splice variants of synapse-associated protein 102 (SAP102) are 
implicated in synaptic remodeling by subunit-specific regulation of NMDARs by 
anchoring these receptors to the synapse [77]. Following this finding, although there is 
not a known cure for addiction, NMDA receptors may be particularly important in 
ameliorating certain symptoms associated with addiction. Interestingly, NMDAR 
inhibitor trazodone, a traditional medication for the treatment of symptoms associated 
with Obsessive Compulsive Disorder (OCD), has been used to successfully reduce 
compulsive drug-foraging in cocaine addicts, although the mechanism behind this are 
unknown [78, 79].  
 
 
Cocaine and Compulsive Symptoms 
 
Although possibly an unorthodox treatment when first implemented for cocaine 
addicts, closer examination shows that several similarities are common among cocaine 
abusers experiencing craving (“jonesing”) and OCD patients, including unwanted, 
intrusive, and anxiety-related thoughts [80], and compulsive and repetitive foraging for 
non-existent drugs. In fact, co-morbid diagnoses of both disorders are not uncommon 
[81]. Ironically, while trazodone inhibits the activity of ionotropic NMDA receptors, 
these receptors are linked at the synaptic surface to the underlying cytoskeleton by 
SAP90 and SAP90 associated proteins (SAPAPs) [82, 83]. While the SAP90 has been 
exhaustively studied ([84], review), relatively little is known about its associated 
SAPAPs. SAPAPs may prove to be an important target in the progression of the 
compulsive symptoms of cocaine addiction. SAPAPs exist in 4 isoforms (SAPAP 1, 2, 3, 
and 4), range in size from 90kDa-120kDa [85], and serve as the intermediary between 
SAP90 at the PSD and the underlying cytoskeleton [86]. All SAPAPs have a conserved 
guanylate kinase domain that is thought to activate NMDA receptors [87], and are 
localized to the soma with the exception of the dendritically localized SAPAP3 [85]. 
SAPAP2 (also known as GKAP in older literature) has been shown to directly improve 
NMDA receptor activity [88]. Although little is known about SAPAP function in general, 
there are no studies that examine their relationship to drug reinforcement. This link is 
tantalizing considering that these proteins are linked to NMDA receptors, compulsive 
symptoms can be induced in rodents by deletion of the SAPAP3 isoform, and these 
effects can be reversed by traditional treatments for compulsivity [89]. In light of the 
success of trazadone in ameliorating compulsive symptoms of cocaine users, exploring 
the role of these proteins in response to cocaine sensitization may lead to targeted 
therapies for treating cocaine dependence. 
 
 Towards the goal of improving the knowledge base of how drugs of abuse create 
addicts and using currently uninvestigated areas of this knowledge base, we focused our 
research studies to the male albino rat, and attempt to uncover how cocaine sensitization 
alters cocaine self-administration, prefrontal glutamate receptors, and mesocorticolimbic 
SAPAPs. Even though there is a wealth of data on the effects of cocaine-sensitization on 
self-administration, few address the effects of sensitization after a period of abstinence 
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using a dose high enough to elicit a response in sensitized animals, yet low enough to 
avoid repeat exposure causing sensitization. We hypothesize that using a consistent low-
dose, cocaine self-administration will yield a significant elevation in drug-seeking 
behavior for psychostimulant sensitized animals. While the population and function of 
iGluRs are known to be altered throughout the mesocorticolimbic system, this effect has 
not been explored in the prefrontal cortex. The prefrontal cortex warrants this 
investigation because of sensitization-induced prefrontal glutamatergic pathology. Also 
absent in the literature are molecular links to observed clinical signs of compulsive 
behavior that can manifest in cocaine addicts, including unwanted obsessive thoughts 
about drugs, ritualistic/repetitive behaviors [90], and compulsive foraging for additional, 
non-existent drug [17]. Although it has been noted in the literature that rodents can be 
induced to display compulsive behaviors by deletion of synaptic SAPAP3 protein, any 
link bridging cocaine sensitization to the SAPAP family of proteins is wholly unexplored. 
For cocaine-induced molecular changes, we hypothesize that acute cocaine exposure 
and/or cocaine sensitization will alter iGluRs levels in the mPFC, and SAPAP levels in 
multiple sites of the mesocorticolimbic system.  
 
To test these hypotheses, we will investigate the effects of psychostimulant 
sensitization on various parameters of self-administration by infusing a low-dose cocaine 
reward proven to not induce sensitization during self-administration (reported here as 0.3 
mg/kg/infusion). We will also investigate the effects of acute cocaine exposure and/or 
cocaine sensitization on iGluRs in the mPFC and SAPAPs in the entire 
mesocorticolimbic circuit through western blotting, immunolabeling of proteins of 
interest, and comparing protein levels to those found in cocaine naïve controls. A limited 
self-administration protocol will also test if SAPAP levels are altered by self-
administration of a low-dose cocaine reward.  
 
Although the personal accounts related to cocaine use are as varied as there are 
drug users in the world, three personal accounts may help to place into to focus the real-
world consequences on people of a disease that is often modeled in a laboratory using 
rodents: 
 
I. “My academic expertise about drugs was a hindrance to my recovery. I 
was convinced my knowledge of drugs would make them more 
manageable. I now realize that this is like a ballistics expert thinking he is 
bullet-proof. My arrogance and delusion would be funny if they hadn’t 
come so close to doing me in.”-Narcotics Anonymous (1987) [91, p. 288] 
II. “The decision-making part of the brain of an individual who has been 
using crystal meth is very interesting. When Carly and Andy were in their 
apartment, they ran out of drugs. They sold every single thing they had 
except two things: a couch and a blow torch. They had to make a decision 
because something had to be sold to buy more drugs. A normal person 
would automatically think, Sell the blow torch. But Andy and Carly sat on 
the couch, looking at the couch and looking at the blow torch, and the 
choice brought intense confusion. The couch? The blow torch? I mean, we 
may not need the blow torch today, but what about tomorrow? If we sell 
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the couch, we can still sit wherever we want. But the blow torch? A blow 
torch is a very specific item. If you’re doing a project and you need a blow 
torch, you can’t substitute something else for it. You would have to have a 
blow torch, right? In the end, they sold the couch.”-Dina Kucera (2010), 
Everything I Never Wanted to Be: A Memoir of Alcoholism and 
Addiction, Faith and Family, Hope and Humor [92, p. 165] 
III. “Crack [Cocaine] is a motherfucker……the cocaine isn’t the problem, it’s 
the money [that one spends on it]. As soon as you get a dollar, it’s the first 
thing you want [to buy].”-Personal communication from Kevin Brown, 
former cocaine addict, on March 15th, 2014 
 
  
 12 
CHAPTER 2.    EFFECTS OF SENSITIZATION ON COCAINE SELF-
ADMINISTRATION 
 
 
Rationale 
 
Cocaine sensitization causes increased drug-induced locomotion, and is also 
thought to increase the reinforcement potential of cocaine under operant training. 
Although there are studies that examine the effects of cocaine sensitization on low-dose 
cocaine self-administration (defined as approx 0.3 mg/kg), there are factors that prevent 
adequate interpretation of the effects of sensitization on self-administration motivation 
and acquisition.  Here, we used a between-sessions model of a low-dose in all self-
administration phases to measure the effects of sensitization on self-administration. After 
acquisition of self-administration, we tested for motivation, extinction, and reinstatement 
on different days to avoid acute cocaine-induced escalation and unwanted sensitization 
during self-administration. Using this low-dose protocol, significantly more sensitized 
animals completed the training protocol under this lower dose when compared to saline 
controls. Differences were not observed for days to complete the training protocol, 
reinforced responses under a progressive ratio (PR) schedule, or active responses during 
extinction. Differences were also not observed for reinstated responses after injections of 
cocaine or yohimbine, a facilitator of reinstatement in cocaine sensitized rats. These 
results suggest that under a consistent sub-sensitizing dose, cocaine sensitization had a 
profound effect on the acquisition of cocaine self-administration behavior. Despite 
differences in acquisition, low-dose self-administration in sensitized animals did not 
result in escalation of drug seeking, or stress/drug primed reinstatement. 
 
 
Background 
 
Cocaine sensitization has long been hypothesized to contribute to the persistence 
of cocaine abuse in addicts. In rats, sensitization is defined as the ability of intermittent 
and repetitive doses of cocaine to cause long-term neuronal modification, and elicit 
elevated drug responses. These modifications are manifested behaviorally, and include 
enhanced drug-induced locomotion, seemingly useless repetitive movements, and 
enhanced acquisition of reinforced responding for cocaine under operant testing. Drug 
self-administration has long been used to examine the reinforcement potential of cocaine, 
and mimics various facets of drug abuse observed in human addicts, including the 
reinforcement of drug concentrations aversive to drug naïve controls, higher break point 
during progressive ratio (PR) testing, and continued reinforcement despite negative 
consequences. Self-administration studies have become an invaluable tool used by 
researchers to study how molecular and behavioral manipulations directly affect the 
reinforcement potential of cocaine. Yet, fewer of these studies examine how cocaine 
sensitization influences self-administration. Among the studies that do examine the 
effects of cocaine sensitization, there are factors that prevent interpretation of the effects 
of sensitization alone on self-administration motivation and acquisition.  
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In examining all the variations in protocol, there are combinations of treatments 
that would alter any resulting cocaine reinforcement caused by cocaine sensitization. 
Drugs of abuse share the common feature of increasing dopamine in the nucleus 
accumbens (Nacc). Yet, the mechanism by which this occurs may vary, along with 
systemic effects and drug-induced neuroadaptations [93]. Rats sensitized to amphetamine 
display behavioral cross-sensitization to the reinforcing properties of cocaine [94], 
enhancement of cocaine seeking by injections of AMPA into the Nacc [95], and 
increased escalation of cocaine self-administration over non-sensitized controls [96]. Yet, 
amphetamine works through a different mechanism than cocaine to increase synaptic 
dopamine [97] which results in more severe dendritic changes when compared to cocaine 
exposed animals [76]. When cocaine and alcohol are combined, the resulting metabolites 
combine to produce cocaethylene [98]. Cocaethylene is longer lasting than both parent 
substances, more toxic than cocaine alone [99], and has a higher binding affinity for the 
dopamine transporter [100]. Due to these traits, cocaethylene not only masks, but 
supersedes any behavioral effects due solely to cocaine. Additionally, chronic stress 
causes alterations in the HPA axis that are linked with long term cocaine use and 
modification of reinforcement responses for cocaine (for detailed reviews see [101] & 
[102]). This ‘priming’ by chronic stress could interfere with any examination of cocaine 
effects by chronic stress mimicking cocaine through increasing Nacc dopamine [103]. 
Stress priming in adolescent animals can sensitize drug naïve animals to cocaine [104], 
and may even render animals vulnerable to relapse [105]. In the study that compared two 
different doses during the course of the experiments, it was reported that all rats treated 
readily learned to self-administer, yet an earlier dose (0.2 mg/kg) was exchanged with a 
higher one (0.8 mg/kg) later in the protocol that is greater than one known to sensitize 
rats during the self-administration protocol [106]. This makes it unclear which dose is 
responsible for the reported effects, and risks sensitizing animals during testing. Another 
study used a non-sensitizing dose and a between-sessions model, but only required the 
animals to respond under a fixed ratio of one response (FR1) for 8 days [107]. Although 
this model spreads drug testing over separate days to avoid cocaine induced 
escalation/tolerance, this particular protocol may not have been stringent enough to 
establish differences between sensitized and non-sensitized animals.  
 
While avoiding issues that muddle the interpretation of results, there are also 
several self-administration techniques that aid in the isolation of any effects caused by 
sensitization. Common in the literature examining the effects of cocaine sensitization on 
self-administration is a limitation on when drug is available to be infused. This limitation 
is included because animals given 24-hour free access to drug can quickly infuse enough 
drug to die from severe cocaine toxicity [108]. One author partially attributed this “loss 
of control” to cocaine-induced stereotypy [109]. In comparison, increasing the labor cost 
associated with drug infusions through the inclusion of a progressive ratio (PR) schedule 
has the ability to increase the reinforcement strength of cocaine self-administration 
(termed salience) by requiring seemingly random, ever-increasing effort to acquire 
subsequent  doses of drug until a breakpoint is reached. At this breakpoint, the animal is 
unwilling to continue responding for the next dose, or cannot reach criteria in the allotted 
time [110, 111]. To accomplish this, PR testing uses a specific formula to generate the 
number of responses needed to achieve the next dose and increases in a dynamic fashion, 
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in contrast to a discrete number of responses under FR [111]. Analysis of breakpoints is 
critical because they serve as a more direct measure of reinforcement efficacy than FR 
responses that increases alongside motivation for drug-seeking [112]. Moreover, the 
efficacy of timeouts and PR testing can be affected by the time course over which the 
entire self-administration experiment takes place, and the length of each session. 
Although desirable for testing the effects of “binge” cocaine exposure, a within-session 
model is maladapted to studies measuring the effectiveness of sensitization. This is 
because prolonged daily cocaine exposure has been reported to either artificially increase 
drug reinforcement [113], or induce short-term drug tolerance [114]. Because of this fact, 
studies designed to test acquisition and maintenance of cocaine responding can be 
hindered by within-session models. For this reason, using a between-sessions model is 
more desirable.  
 
Other than altering the operant protocols for self-administration, perhaps the 
simplest technique is to alter the concentration of each cocaine infusion (“dose”) to be 
administered. The drug concentration is of crucial importance, and care must be taken in 
consideration of the self-administration dose. For example, although higher doses 
increase responses for drug, it may also be noxious to test animals depending on exposure 
history [115]. Yet, it is desirable to use a dose high enough to be reinforcing, as a dose 
that is too low will not elicit responding regardless of past history of cocaine exposure 
[116]. 
 
Operant testing for self-administration often involves several distinct phases. 
First, after implantation of an indwelling intravenous catheter, animals must be trained to 
associate operant responding with drug availability, a phase known as acquisition (or 
“training”). Second, after animals have met the criteria for training, the main testing 
phase follows in which different facets of operant responding are tested. This can range 
from responding under various schedules, to extinction of drug responding, to possible 
reinstatement of the responding behavior. Regardless of the findings that cocaine self-
administration prolonged over days can result in either elevated responses due to cocaine-
induced enhanced locomotion or decreased responses due to acute tolerance-like effects, 
intermittent exposure to cocaine during self-administration over multiple days regardless 
of session length, results in an increase in reinforcement potential [117] and cocaine 
sensitization [106]. Unfortunately, there has been a noticeable dearth of studies 
specifically examining this facet of the addiction process in drug addicts [14], although a 
limited studies in non-drug users injected with amphetamine over 4 days report an 
increase in spontaneous blink rate and euphoria [15, 16].   
 
In this manuscript, we used various methods to limit cocaine exposure to 
determine if cocaine sensitization affects acquisition of cocaine self-administration. 
These experiments will use a dose reported to be low enough to avoid cocaine-induced 
hyperactivity/ tolerance (defined here as 0.3 mg/kg) to isolate any effects of cocaine 
sensitization, and to examine any altered responding under acquisition (training), PR 
schedule, extinction, and reinstatement of drug self-administration with challenge dose of 
cocaine (15 mg/kg). We used amphetamine pretreatment and yohimbine induced 
reinstatement as experimental controls. As justification, amphetamine pretreated rats are 
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not only cross-sensitized to cocaine [94], but display enhanced escalation in cocaine self-
administration over non sensitized controls [96]. Also, the ability of yohimbine, an 
alkaloid that elicits reinstatement of extinguished cocaine self-administration [118], was 
used in reinstatement testing to evaluate the efficacy of cocaine exposure during 
reinstatement. 
 
 
Methods 
 
 
Sensitization 
 
68 male Sprague-Dawley rats (Harlan Laboratories), weighing 250 g upon arrival 
were placed on a reverse daylight cycle (light: 1900hrs-0600/ dark: 0600-1900) and 
allowed to acclimate to for 5-7 days. Animals were allowed food and water ad libitum. 
After the acclimation period, subjects received intraperitoneal (I.P.) injections of cocaine, 
amphetamine, or saline only in identical volumes. Animals received an IP injection of 15 
mg/kg cocaine, 1.5 of mg/kg of d-amphetamine, or saline on Day 1 and then every third 
day until a total of 5 injections had been administered. On the day following the last 
injection, sensitized animals were tested alongside saline-injected control rats for 
enhanced drug induced locomotion in infrared home cage monitors (Accuscan 
Instruments Inc.) with 16 infrared beams spaced approximately 0.8 inches apart. After a 
1-hour baseline, rats from all groups received a 15 mg/kg I.P. challenge dose of cocaine, 
and were placed back into the test chamber for an additional 2 hr to record cocaine-
induced activity.  
 
 
Jugular Catheter Implantation  
 
In the 24-72 hours following the locomotion test, rats were anesthetized with 
ketamine/xylazine cocktail (80 and 10 mg/kg, respectively) and implanted with an 
indwelling silastic unilateral jugular catheter [119].  I.P. injections of 0.5 mg/kg 
Rimadyl® (Carprofen, injectable) for pain control and catheter injected 0.1 ml of 
Baytril® (Bayer Corporation) were given immediately after surgery. Rats were allowed 
to recover for at least 5 days before testing. Catheters were flushed with 0.1 ml of 
Baytril® daily for the first 7 days after implantation, and once every 7 days following 
until the conclusion of self-administration testing. 
 
 
Self-Administration Training 
 
Nine days following catheter implantation, rats were tested for catheter patency 
by experimenter-administered perfusions of 0.1 ml fast acting/clearing Brevital® 
(Methohexital Sodium) through the catheter. If the catheter was unobstructed, the 
perfusion immediately anaesthetized the animal for approximately 1 minute. If animals 
were not anaesthetized, we concluded that the catheter was obstructed and the animals 
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were immediately humanely killed by carbon dioxide asphyxiation. One day following 
the Brevital® patency test (Ten days after the last IP sensitization injection), rats were 
placed in operant behavior chambers (Med Associates Inc.) connected to a delivery 
system that delivered a 20-second 100 μl infusion of 0.3 mg/kg cocaine solution. The 
delivery system used operated at 3.33 revolutions per minute (RPM), and was capable of 
infusing 1.0 mL/minute.  The chamber contained two active levers located side-by-side 
on the front “wall”, a circular cue light on the wall over each lever, and a house light on 
the back wall opposite the levers. At the start of each session with the house light off, the 
cue light over the active lever was activated for 20 seconds. The cue light was then turned 
off, the house light turned on, and the “active” and “inactive” levers presented. When 
pressed, the active lever activated the delivery pump to infuse cocaine, activated a cue 
light over the lever, and turned out the house light. Pressing the inactive lever had no 
programmed consequences except event recording. To successfully complete the 
acquisition phase, animals were required to make nine infusions within 3 hours under the 
FR1 and FR2 schedules. Rats were first trained to self-administer cocaine under an FR1 
schedule, during which every response on the correct lever resulted in a 20-second 100 μl 
infusion of cocaine for up to 9 responses within 3 hr. Upon successful completion of the 
FR1 schedule rats were challenged under an FR2 schedule, during which every second 
response resulted in an infusion, for up to 9 cocaine infusions. Rats were given 5 days to 
complete both the FR1 and FR2 schedules, unless the FR1 training was completed on the 
5th day. In this case, the rats were given one extra day to complete FR2. Any animals that 
did not meet these criteria were humanely euthanized by carbon dioxide asphyxiation in 
accordance with UTHSC IACUC protocols. After each session, behavioral chambers 
were thoroughly cleaned with 70% ethanol and stocked with fresh sanitized woodchip 
bedding. 
 
 
Self-Administration Testing  
 
On the day following completion of training, subjects were then required to 
respond for cocaine under a PR schedule [111] for 4 days. If the subject reached 30 
infusions, the session was terminated before the three-hour time limit. After the 
conclusion of PR training on the same day, catheter patency was tested by perfusion of 
0.1 ml of Brevital®. The following day, subjects were placed on an extinction protocol 
for 3 days, during which cocaine was replaced by cocaine on the PR schedule. This 
extinction protocol also inactivated the cue light when the active lever was pressed. 
Following extinction training, the ability to re-instate responding was tested using a 
modified PR protocol in conjunction with extinction. Using this method, half of the 
animals were tested under ‘reinstatement 1’ conditions on the first day in which 15 mg/kg 
cocaine or 2 mg/kg yohimbine was injected IP. On days 2-4, the extinction protocol 
described above was repeated. On day 5, rats were tested under similar conditions as the 
first reinstatement day except an injection of saline was administered.  The remaining 
half of animals were tested under similar conditions except saline was delivered after the 
first extinction sessions and yohimbine/cocaine was delivered after the second extinction 
sessions. At the conclusion of self-administration, rats were euthanized by carbon dioxide 
asphyxiation in accordance with UTHSC IACUC protocols. 
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Analysis 
 
All statistical calculations were performed using Prism 5 (Graphpad). Analysis 
consisted of a percentage of total animals of each treatment group that completed training 
was analyzed by a Chi-Square analysis for trends, and series of two-way ANOVA tests 
for analyzing the post-sensitization cocaine challenge dose, sensitized animals for PR 
testing, Extinction phase 1, Reinstatement phase 1, Extinction phase 2, and Reinstatement 
phase 2.  
 
 
Results 
 
Verified by challenge injections of cocaine, all animals subjected to the 
sensitization protocol were sensitized by cocaine exposure, or proven to be cross-
sensitized to cocaine by amphetamine exposure (F=9.319 (2,33), p= 0.0003, Figure 2-1). 
Significantly higher photocell counts over controls were displayed by cocaine pretreated 
and amphetamine pretreated animals. On the following day, the self-administration 
experiments commenced. Although animals did not show any blockages in the 
intravenous catheter or signs of surgery related infection or discomfort, many of the 
saline control animals failed to complete the training protocol in the allotted 5-day time 
period compared to the drug-treated controls (Figure 2-2). A chi square analysis for 
trends revealed a difference between untreated and treated animals for the numbers of 
animals that completed the training protocol (x2(1) = 4.669, p = 0.0307, Figure 2-3). 
Among the animals that did complete the training protocol, the self-administration 
protocol continued as outlined, although with a ratio skewed towards a greater 
representation of drug treated animals. Using a two way ANOVA, no differences 
between treatment groups were observed during the PR schedule, extinction schedule, or 
yohimbine/cocaine induced reinstatement. For these schedules, analyzed behaviors 
included active lever responses, inactive lever responses, infusions earned, and session 
duration.  
 
 
Discussion  
 
Although not significant for most cases, several interesting trends emerge among 
these data. Firstly, the failure of saline controls to complete training is a surprisingly 
novel result. It is known that the dose response curve of sensitized animals is shifted, 
which would explain the result of drug-sensitized animals completing the training with 
more frequency over control animals. Yet, upon further examination of data, it was also 
noted that for saline controls that did not complete training, not only did the animal not 
meet criteria over the initially allotted five days, but often stopped responding completely 
after the first day. This would suggest that this 0.3 mg/kg/infusion dose was not 
reinforcing to control animals. 
 
The technique used to deliver drug to the animal could have affected the self-
administration results in our study. In fact, the published study that our self- 
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Figure 2-1. Graphic Flowchart for Self-Administration Protocol.  
Animals segregated by pretreatment are indicated at the top middle: the blue box 
containing “S” represents control animals, the green box containing “C” represents 
cocaine sensitized animals, and the red box containing “A” represents amphetamine 
sensitized animals. The animals where then tested using the same paradigm, and under 
reinstatement animals were randomly separated into two counterbalanced groups. 
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Figure 2-2. Sensitization Verification by Infrared Home Cage Monitors.  
Testing included a 1-hour activity baseline, followed by a 2-hour activity recording that 
was immediately preceded by a challenge dose of 15 mg/kg cocaine I.P. injection. 
Photocell counts for were significantly higher in cocaine challenged cocaine and 
amphetamine (Amp) sensitized animals, indicated by “*”. 
 
  
C o
n t
ro
l (
n =
4 0
)
C o
c a
in
e
(n
= 1
4 )
A m
p
(n
= 1
4 )
0
5 0 0 0
1 0 0 0 0
1 5 0 0 0
C o c a in e C h a lle n g e
T re a tm e n t G ro u p
P
h
o
to
C
el
lC
o
u
n
ts *
*
 20 
 
Figure 2-3. Chi Square Analysis Comparing Treated and Untreated Animals 
During Acquisition. 
Under Chi-Square analysis, there is a trend difference between treated and untreated 
animals acquiring self-administration behavior during the FR1/2 self-administration 
training protocol. Notice that more untreated (saline) animals were tested, and a 
significantly greater proportion of saline animals fail to acquire the behavior. 
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administration experiments were based on used faster pumps that delivered 1.6 ml/minute 
[95], compared to ours that infuse drug at approximately 1.0 ml/minute. The relatively 
slow speed of the self-administration pumps could have lowered the efficacy of the 
cocaine delivery system, as faster speeds of delivery results in increased motivation 
during self-administration in rats [120, 121] and humans [122, 123]. This explains why 
all routes of cocaine absorption used by humans facilitate concentrated, rapid delivery of 
concentrated drug doses into the bloodstream [124, 125]. Indeed, without a concurrent 
increase in delivery speed, independent studies report that under a significantly higher 
dose (0.8 mg/kg), not only did most animals complete the training phase but also an 
increase in cocaine self-administration under PR was significantly increased. 
Additionally, the study these experiments were based on precipitated reinstatement by 
intracranial injection of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid  
 (AMPA), an agonist that provides greater stimulation properties by displaying 2-3 times 
the affinity for AMPA-type glutamate receptors than the endogenous glutamate present in 
our sensitized animals [126]. Second, animals were sensitized in a different environment 
than the operate chamber. Treating subjects in the same environment as the one used for 
operate testing is known to increase the locomotor effects of cocaine sensitization [127, 
128]. The level of sensitization in our sensitized subjects may not have been sufficient to 
alter self-administration over cocaine naïve controls. 
 
In conclusion, the significant increased number of sensitized animals acquiring 
self-administration at this dose is a novel finding. These results may suggest that animals 
not vulnerable in some way to the reinforcing effects of cocaine will find much lower 
doses of drug than previously thought reinforcing, and cocaine naïve controls are much 
more resistant than previously believed to acquiring cocaine self-administration. 
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CHAPTER 3.    EFFECTS OF COCAINE SENSITIZATION ON SAPAP LEVELS 
IN THE MESOCORTICOLIMBIC SYSTEM 
 
 
Rationale 
 
In humans, symptoms associated with cocaine use are reported to include 
obsessive components including compulsive foraging for drug and unwanted/intrusive 
thoughts of drug use, even among abstinent users. This obsessive feature of sensitization 
may be especially instrumental in relapse, and is associated with abnormal glutamate 
transmission in the mesocorticolimbic system. For various regions of the 
mesocorticolimbic system, we examined the effects of cocaine sensitization and acute 
cocaine exposure on SAPAPs. Rats were sensitized to cocaine over 4 days (15 
mg/kg/day) and along with matched sham-injected controls, were either exposed to an 
acute dose or saline injection after 1 day, 2 weeks, or 3 weeks of cocaine abstinence. We 
observed that cocaine sensitization results in significantly lower SAPAP protein levels in 
the dorsal medial prefrontal cortex (mPFC) and the nucleus accumbens (Nacc). In the 
nucleus accumbens core, a significant reduction in SAPAPs was only observed for 
sensitized animals exposed to drug on test day. In the dorsal prefrontal cortex, effects 
were less dependent on sensitization, and a reduction was observed in cocaine naïve 
controls and sensitized rats. This occurred in response to both acute exposures on test day 
and prolonged abstinence.   
 
In a separate self-administration study, cocaine naïve rats were implanted with 
indwelling jugular catheter and lever pressed for a cocaine reinforcer (0.3 
mg/kg/infusion) under FR1 schedule for 10 days, yoked to animals that received saline 
infusions simultaneously. In test animals, increased SAPAP protein levels were observed 
for all 4 SAPAPs in the dorsal mPFC, SAPAP3 in the ventral mPFC, and SAPAP 2 and 4 
in the nucleus accumbens core. In addition, SAPAP levels in the mesocorticolimbic 
circuit displays multiple significant alterations upon acute exposure at 2-24 hrs post 
exposure.  Exploration of how these proteins are altered in sensitized animals and by 
contingently-administered cocaine may serve in identifying potential pharmacological 
treatments for drugs of abuse.    
 
 
Background 
 
Following the growing appreciation of glutamate in the addiction process, there 
has been a growing interest in glutamate receptors (GluRs) and how their physiology is 
altered by cocaine sensitization. These receptors are both ionotropic (iGluRs) and 
metabotropic (mGluRs), and work together to affect glutamate transmission. 
Metabotropic GluRs modulate cell responses indirectly through G-protein cascades, and 
alter the responses to glutamate by preventing hyperpolarization [129] and presynaptic 
silencing [130]. Despite the global influence of mGluRs, the direct and immediate effects 
of glutamate are mediated by pore-containing iGluRs that directly contribute to the post-
synaptic current. The subunits composing iGluRs determine receptor function, and also 
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display a limited ability to regulate mGluR activity [131]. Postsynaptically, these 
receptors consist in three distinct varieties: excitatory receptors that are activated by 
AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), receptors sensitive to 
NMDA (N-Methyl-D-aspartate), and a less well understood class of kainite-sensitive 
receptors [54]. With the exception of the prefrontal cortex, the details of how 
mesocorticolimbic AMPA/NMDA receptors are affected in number and function by 
cocaine exposure are documented, and trend towards a greater contribution of excitatory 
post-synaptic currents [132]. In schizophrenia and cocaine sensitization, increased 
AMPA receptor input and elevated dendrite number are evidence of enhanced glutamate 
sensitivity [133].  
 
Although these receptors function individually, the physical clustering of multiple 
receptors facilitates efficient neurotransmitter responses [84]. These multi-receptor 
complexes are anchored to the surface of the PSD, and are associated with an elaborate 
transduction array below the cell surface that is connected to the neuronal cytoskeleton 
[84].  This array also anchors and condenses iGluR transduction complexes. This is an 
important function because mechanisms affecting the expression of cocaine sensitization 
include iGluR adaptations and intracellular signaling cascades. Similar to mGluRs, 
iGluRs have the ability to initiate cell signaling through their intracellular domains to 
regulate synaptic responses. NMDA receptors regulate the surface expression of AMPA 
receptors through the Ras-ERK pathway by NR2A-containing NMDARs promoting 
AMPAR expression, and NR2B subunits depressing this expression [72]. AMPA 
receptors even have the ability to remove themselves from the synapse via the GluR2 
subunits through BRAG2-mediated endocytosis [73]. However, these signaling 
mechanisms may not only regulate the functional ratio of AMPA/NMDA receptors, but 
also alter the activity of receptors present at the synapse. For example, phosphorylation of 
the GluR1 AMPA subunit by PKC at Ser(831) increases AMPA channel conductance 
[74]. In addition to these phenomena, cytoskeleton remodeling is known to facilitate 
drug-induced habit formation in an unknown fashion [75].  
 
In cocaine sensitized rats, clear and dramatic morphological changes occur in 
MSNs of the nucleus accumbens (Nacc) [76].  Splice variants of synapse-associated 
protein 102 (SAP102) are implicated in synaptic remodeling by subunit-specific 
regulation of NMDARs, anchoring these receptors to the synapse [77]. Following this 
finding, although there is no cure for addiction, NMDA receptors may be particularly 
important in ameliorating certain symptoms associated with addiction. Interestingly, 
trazodone, an NMDAR inhibitor and traditional medication for the treatment for 
obsessive compulsive disorder (OCD), has been used to successfully reduce compulsive 
drug-foraging in cocaine addicts. Yet, exactly how trazodone exerts this effect is 
unknown [78, 79]. Although an unorthodox treatment for cocaine addiction, closer 
examination shows that several similarities are shared by cocaine addicts and OCD 
patients. These similarities include unwanted/intrusive anxiety-related thoughts and 
compulsive and repetitive behavior [80]. In fact, co-morbid diagnoses of both disorders 
are not uncommon [81]. Yet while trazodone inhibits the activity of ionotropic NMDA 
receptors, these receptors are linked at the PSD to the underlying cytoskeleton by 
SAP90/PSD-95 which recruits others proteins to the synapse [84]. One of the families of 
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proteins that are recruited the receptor/SAP90 complex are SAP90-associated proteins, 
the commonly used acronym for which is SAPAP [134]. While SAP90 has been 
exhaustively studied ([84], review), relatively little is known about its associated 
SAPAPs. These proteins may be important proteins in the progression of the compulsive 
symptoms of cocaine addiction. Four isoforms of SAPAPs exist (SAPAP 1, 2, 3, and 4) 
and range in size from 90kDa-120kDa [85]. These proteins serve as the intermediary 
between SAP90 at the PSD and the underlying cytoskeleton [86]. These proteins also 
contain a conserved guanylate kinase domain that has been shown to activate NMDA 
receptors [87]. Specifically, SAPAP2 has been shown to directly improve reduced 
NMDA receptor activity [88]. Although little is known about how SAPAPs generally 
function, and nothing of their relation to drug reinforcement, their exploration in this role 
is tantalizing considering that these proteins are linked to NMDA receptors. This 
argument is bolstered by the finding that inhibiting GKAP degradation in the 
hippocampus results in a phenotype strikingly similar to Nacc MSNs due to cocaine 
sensitization [135]. In light of the success of trazodone in ameliorating the compulsive 
symptoms of cocaine users, exploring the role of these proteins in response to cocaine 
sensitization may lead to targeted therapies for treating cocaine dependence. 
 
While their exact functions in addition to receptor clustering are not known, 
SAPAPs (also called DAP, or GKAP in older literature) also interacts with dynein in 
spindle formation [136], can recruit nNOS to the post synaptic density [137], and can be 
removed from the synaptic density due to increased excitatory activity [138]. SAPAPs 
also seem to be localized exclusively with cholinergic/glutamatergic synapses, and show 
differential expression spatially, with SAPAP3 being restricted to the dendrite and all 
others to the soma [139]. In mice, deletion of SAPAP3 in the striatum results in synaptic 
disorganization, excess grooming to the point of skin lesioning, altered corticostriatal 
transmission, and compulsive anxiety-associated behaviors [89]. In these animals, the 
resulting compulsive characteristics can also be rescued by viral transfection of full 
length SAPAP3 transcripts or treatment with fluoxetine, a drug treatment for OCD [89]. 
In humans, rare missense mutations in SAPAP3 are even implicated in patients suffering 
from the OC-spectrum disorder tricholliomania (compulsive hair eating) [140], giving 
clinical significance to information gained from model organism studies.  
 
In addition to ionotropic iGluRs, SAPAPs may also influence mGluRs. According 
to one study, SAPAP3 deletion can cause striatal mGluR5-dependent silencing of AMPA 
receptors in addition to compulsive grooming [141]. Additionally, the mGluR5 agonist 
DHPG in the mPFC is sufficient to induce cross-sensitization to cocaine, and antagonist 
MTEP sufficient to prevent it [142], yet any links to SAPAPs are absent. To understand 
how SAPAPs may affect mGluR function, an understanding of the role of mGlur5 in the 
regulation of glutamate transmission is required.  
 
SAPAP disruption may help to describe mGluR5 silencing, by considering the 
influence of Homer on mGluRs. The Homer scaffolding protein family regulates 
prefrontal glutamate transmission by clustering mGluR5 receptors, which is a process 
that is dependent on an association between Homer and a protein complex including 
GKAP (SAPAP1) [143]. Homer interacts with mGlur5 through its EHV1 domain to 
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cluster together mGluR5 receptors, yet the Homer1a isoform lacks the necessary c-
terminal domain to cross-link receptors and perform this function [143]. Lack of 
clustering of mGluR5 receptors, similar to NMDA receptors, would lower the efficiency 
of these receptors. As evidence of this phenomena, 10-days of cocaine self-administration 
in rats causes a long term elevation in Homer1a/b in the ventral mPFC [144]. Cocaine-
primed reinstatement can be extinguished in these animals by knockdown of Homer1a in 
the ventral mPFC, or increased expression of an isoform able to crosslink mGluRs, 
Homer1c [144]. Note also that increased stimulation concurrently increases Homer1a 
levels [145]. Considering the role of Homer in clustering mGlur5 receptors, this result 
may also be accompanied by increased excitatory glutamate transmission in the ventral 
mPFC by cocaine exposure.  
 
When considering this result in the ventral mPFC, recall that activating mGluR5 
receptors in the mPFC can initiate behavioral sensitization, and inhibiting these receptors 
can prevent it. In addition, electrical stimulation enhances the locomotor effects of 
behavioral sensitization by stimulation of NMDA receptors (“kindling”) [146], and 
activation also uncouples them from SAPAPs [138]. Even though these results are 
seemingly in conflict with one another, they are evidence that the dorsal and ventral 
mPFC have differing roles in the sensitization process that can be understood by 
examining how these regions act in concert with each other.  
 
The dorsal mPFC is critical to the development of cocaine sensitization, and 
lesioning this area will prevent the initiation and expression of sensitization from 
occurring [147]. Conversely, administering the GABA agonist baclofen in the ventral 
mPFC will prevent acute cocaine-induced motor activity and initiation of sensitization, 
but not its expression [148]. Considering these studies together, a working model of 
changes in the dorsal and ventral mPFC in relation to cocaine sensitization can be 
assembled. In response to cocaine exposure, the dorsal mPFC is the seat of the initial 
mPFC changes of behavioral sensitization. Increased glutamatergic transmission in this 
region stimulates all glutamate receptors. This stimulation uncouples NMDA and 
mGluR5 receptors at the PSD, which lowers their efficiency. It also uncouples NMDA 
receptors from GKAP, and mGluR5 from complex-forming Homer proteins substituted 
with Homer1a. This would explain why mGluR5 agonists can cause sensitization and 
antagonists can inhibit sensitization, as antagonists can prevent receptor uncoupling. 
Additionally, if the dorsal mPFC is lesioned, this process is thwarted and behavioral 
sensitization cannot occur.  If not prevented in some form, increased glutamatergic 
transmission will affect the ventral mPFC and produce similar uncoupling of inhibitory 
receptors. While GABA agonists can prevent the effects of enhanced glutamate 
transmission in the ventral mPFC caused by acute cocaine and the initiation of behavioral 
sensitization, they cannot reverse changes already present. This would explain why 
baclofen is ineffective in preventing the expression of behavioral sensitization. Reversing 
the effects of sensitization in the ventral mPFC can prevent behaviors associated with 
sensitization (i.e. substituting Homer1a for Homer1c to prevent cocaine-induced 
reinstatement). Also note that all of the previously-attributed effects of cocaine exposure 
can also vary if cocaine is experimenter-administered (non-contingent) or if animals 
administer the drug to themselves (contingent). Considering that dopamine is 
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preferentially increased more in the Nacc core than the shell in response to contingently-
administered cocaine, it will be of value to determine how contingent cocaine exposure 
affects SAPAP levels. 
 
Motivated by these published data, we propose here to investigate if behavioral 
sensitization and acute cocaine challenge are associated with changes of SAPAP protein 
isoforms in the ventral and dorsal mPFC, Nacc core and shell, dorsal striatum, substantia 
nigra, and ventral tegmental area. In contrast to these studies relying upon non-contingent 
(experimenter-administered) drug, we will also investigate if and how SAPAP levels in 
the mesocorticolimbic circuit are altered by contingent (self-administered) cocaine 
exposure. This is an important detail to study considering the effects of cocaine can vary 
under these two treatment regimens even in non-sensitized animals acutely exposed to 
cocaine [149]. To further characterize how SAPAPs change in response to cocaine, we 
will also investigate the time course of any changes in response to acute cocaine 
exposure. 
 
 
Methods  
 
 
Animal Subjects 
 
Upon delivery, male albino Sprague Dawley rats weighing approximately 250g 
on arrival were acclimated to reversed light cycle housing (LIGHTS OFF - 05:00-18:00 
hrs, LIGHTS ON- 18:00-05:00 hrs) for 3 days. Rats were housed individually and 
received food/water ad libitum for the duration of their lives.  
 
 
Abstinence Studies 
 
Rats were sensitized by receiving an injection of cocaine (15 mg/kg) once a day at 
12:00-13:00 for 4 days. A separate group of control animals received sham (saline) 
injections on the same schedule as sensitized test animals. Next, both groups of animals 
were divided into 3 different cohorts that underwent a period of abstinence for 21 days (3 
weeks), 14 days (2 weeks), or 1 day. On the day following the abstinence period, 
sensitized animals were tested alongside time-matched and sham-injected control rats for 
any enhanced drug induced locomotion in infrared home cage monitors (Accuscan 
Instruments Inc.). A baseline measure of motor activity was obtained for 1 hr. Next, 
sensitized animals either were challenged with a dose of 15 mg/kg I.P. cocaine 
(cocaine/cocaine group) or received a sham injection of saline (cocaine/saline group). 
Cocaine naïve controls were examined alongside sensitized animals and either received a 
single injection of cocaine on test day (saline/cocaine group) or an injection of saline 
(saline/saline). Regardless of the injection administered, the challenge session was 
concluded after 2 hours.  Immediately after the session, rats were sacrificed by guillotine 
without anesthesia.  
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Acute Time Course Studies 
 
Acutely exposed animals were injected (I.P.) with 15 mg/kg cocaine and killed at 
either 2 hours, 4 hours, 8 hours, 12 hours, or 24 hours post-injection. Control animals 
were also killed at these same time points, and were sham-injected with saline. For 
methods detailing guillotine and tissue harvesting procedure, see “Tissue Harvesting” 
below.  
 
 
Jugular Catheter Implantation 
 
For self-administration animals, on the day of surgery subjects were anesthetized 
with ketamine/xylazine cocktail (80 mg/kg and 10 mg/kg, respectively) and implanted 
with a indwelling silastic unilateral jugular catheter [150], and given a I.P. injection of 
0.5 mg/kg Rimadyl® (Carprofen, injectable) for pain control and catheter injected 0.1 ml 
of Baytril® (Bayer Corporation) at the conclusion of surgery. Rats were then allowed to 
recover for at least 5 days before testing, and catheters were flushed with 0.1 ml of 
Baytril® daily for the first 7 days after implantation, and once every 7 days following 
until the conclusion of self-administration testing. 
 
 
Self-Administration Training 
 
One day prior to self-administration testing, rats were tested for catheter patency 
by experimenter-administered perfusion of the 0.1 ml of fast acting/clearing Brevital® 
(Methohexital Sodium). The day following the 5-day recovery period after surgery, rats 
were placed in operant behavior chambers (Med Associates Inc.) connected to delivery 
system that delivered a 10-second 100μl infusion at 10 revolutions per minute (RPM). 
This system delivered a concentration of approximately 0.3 mg/kg/infusion of cocaine 
solution. Two levers were presented at the start of each session. These levers were an 
“active” lever (response activated the delivery pump to infuse cocaine, activated a cue 
light over the lever, and turned out the house light), and an “Inactive” lever (no 
programmed consequences for animals). Each animal actively infusing cocaine was 
“yoked”, meaning its responses were replicated in a separate operant chamber containing 
a cocaine naïve control animal connected to an identical pump that administered saline, 
not cocaine. Yoked animals had no control over the actions of the levers or the lights. For 
the next 10 days from 1200 to 1500 hrs, rats were allowed to self-administer cocaine for 
3 hrs each day under fixed ratio 1 (FR1). After each session, behavioral chambers were 
cleaned with 70% ethanol and stocked with fresh sanitized woodchip bedding. Upon 
successful completion of the last session, rats were tested again for catheter patency. 3 
weeks following the end of the last self-administration session, animals were sacrificed 
by guillotine without anesthesia.  
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Tissue Harvesting 
 
Tissue harvesting procedures were identical for all experiments. Immediately 
following guillotining, rat brains were removed intact from the skull and placed on ice. 
The brain was then dissected for the medial prefrontal cortex (mPFC, separate dorsal and 
ventral), nucleus accumbens (Nacc, separate core and shell regions), dorsal striatum (Str), 
substantia nigra (SN, combined pars reticulata/compacta), and ventral tegmental area 
(VTA) using established protocols [151]. Immediately after removal of each region, 
samples were placed on dry ice. From the time of guillotining to the sample incubation in 
dry ice, less than 3 min elapsed. For longer term storage, samples were stored at -80°C. 
All animal experiments were conducted in accordance with accordance with UTHSC 
IACUC protocols. 
 
 
Initial Preparation, Protein Assay, and Immunoblotting 
 
Whole tissue samples were sonicated in 2% SDS and centrifuged at 13,000 X g 
for 30 secs. To obtain the protein concentration of the sample, 200μl of this whole tissue 
sample preparation was analyzed in triplicate using a Bio-Rad® DC™ Protein Assay Kit. 
The triplicate readings were average together, and this average was used as the protein 
concentration.  An aliquot of tissue sample was diluted to 2.0 μg protein/μl with 2% SDS. 
An aliquot of this diluent was diluted to 1 μg protein/μl with an equal volume of 2x 
electrophoresis sample buffer [final concentration after dilution=50 mM Tris HCl (pH 
6.7), 4% glycerol (wt/vol), 2% SDS, 5 mM dithiothreitol and bromophenol blue (0.01 
mg/ml)].  Proteins (20 μg/lane) were separated by size on a 10% SDS-polyacrylamide gel 
transferred to Immobilon-P PVDF transfer membranes (Millipore) in Towbin’s-SDS 
transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol, and 0.01% SDS) at 100V, 
0.35 A for 1-hr at room temperature with the transfer apparatus packed in ice. After 
transfer, the membrane was removed from the transfer apparatus and was left to dry 
overnight at room temperature. 
 
Membranes were reactivated after 12-hrs using 1x 20-sec methanol wash, 
followed by 2x 30-sec washes in ddH20, 1x 10-min wash in ddH20, and 1x 15-min wash 
in TBST. Membranes were then blocked in TBST containing 5% nonfat dried milk 
(NFDM, Blotting Grade Blocker, Bio-Rad) for 1-hr at room temperature with agitation. 
The membrane was then washed once with TBST for 5-min and incubated with the 
primary antibody (SAPAP1,SAPAP2,SAPAP3,SAPAP4 at 1:12,500; Pro-Sci Inc., 
Poway, CA) diluted in TBST  containing 0.5% NFDM for 1-hr. As an experimental 
control, all throughout the labeling process, another portion of each corresponding 
membrane was concurrently probed with an anti-beta tubulin antibody (Sigma Aldrich). 
The membranes were then washed once for 15-min, and then twice more for 5-min in 
TBST followed by 1-hr incubation with agitation at room temperature with horseradish 
peroxidase-conjugated goat anti-rabbit immunoglobulin G (Pro-Sci) diluted 1:5000 in 
TBST containing 0.5% NFDM. After this incubation, the membrane washing technique 
following primary antibody incubation was repeated, and the antigen-antibody-
peroxidase complex was detected by enhanced chemiluminescence (West Femto 
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Substrate, Thermo Scientific) according to the manufacturer’s instructions and visualized, 
analyzed and quantified by computer-assisted densitometry using a Bio-Rad Molecular 
Imaging System using Quantity One Imaging Software. After visualizing, the membranes 
were then stripped using 0.1 M glycine stripping buffer (pH=2.2) containing 1% (v/v) 
Tween-20. After each stripping, the protocol was restarted at the steps mentioned above 
after methanol reactivation until all SAPAPs were probed. 
 
 
Analysis 
 
In analyzing western blots, each SAPAP/beta tubulin band in each sample lane 
was measured and using the imaging software, its adjusted percent volume was 
calculated, globally subtracting any background present. . Beta tubulin was chosen as an 
unchanging control due to the absence of literature reporting cocaine-induced changes in 
quantity, or post-translational modifications in contrast to alpha tubulin [152, 153]. Each 
SAPAP adjusted percent volume value was then divided by its corresponding beta tubulin 
value using Microsoft Excel for each sample after every labeling with each primary 
antibody. For self-administration studies, data were collected for each test animal only, as 
the data for yoked controls was non-existent and all experiences were linked to the active 
responses of test animals. All statistical calculations were performed using Prism 
(Version 5, Graphpad Software Inc.), including SEM for all analysis, unpaired t-test for 
SAPAP in self administration test and yoked rats, and for examining acutely treated 
animals against their time matched sham injected controls. One-way ANOVA analysis 
(Newman-Keuls multiple comparison post-test) was used for all other analysis. 
 
 
Results 
 
For general trends, SAPAP levels in the mPFC decreased 2-8 hrs after acute 
cocaine exposure, and began to recover to baseline levels at 12 hrs (Figure 3-1). In the 
dorsal mPFC, when compared to time-matched cocaine naïve controls, several SAPAPs 
displayed a decrease at multiple time points. SAPAP1 was significantly reduced (F= 
8.315 (5, 32), p= 0.0001, Figure 3-2A) at 2 hrs, 4 hrs, 8hrs, and 24 hrs. SAPAP2 was 
significantly reduced (F=5.013 (5, 32), p= 0.0017, Figure 3-2E) at 2 hrs, 4 hrs, and 12 
hrs after acute cocaine exposure. SAPAP3 was significantly reduced (F=8.630 (5, 32), p= 
<0.0001, Figure 3-2C) at 8 hrs, and 24 hrs after acute cocaine exposure. SAPAP4 was 
significantly reduced (F=5.249 (5, 32), p= 0.0012, Figure 3-2G) at 2 hrs, 8 hrs, and 24 
hrs after acute cocaine exposure. SAPAPs were also decreased in a time-dependent 
manner in the ventral mPFC. SAPAP1 was significantly reduced in acutely exposed 
animals (F=7.278 (5, 32), p= 0.0001, Figure 3-2B) at 2 hrs, 4 hrs, 8 hrs, and 24 hrs after 
acute exposure. SAPAP2 was reduced (F= 3.697 (5, 32), p= 0.0094, Figure 3-2D) at 4 
hrs and 8 hrs. SAPAP3 (F=3.961(5, 32), p= 0.0066, Figure 3-2F) and SAPAP4 
(F=4.104, p= 0.0054, Figure 3-2H) were only significantly reduced at 8 hours after acute 
exposure. Significant changes were also observed at multiple time points for other 
regions examined (Table 3-1, n= 4 and DFn,DFd= 5,32 for all groups). 
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Figure 3-1. Acute Cocaine Exposure Induces a Transient Reduction in Prefrontal 
SAPAP Levels.  
In the dorsal (top, A) and ventral (bottom, B) mPFC, protein levels for SAPAPs 1 
through 4, SAPAP levels trend towards a reduction at 2, 4, and 8 hours. This trend begins 
to return to baseline levels for cocaine naïve time-matched controls at 12/24 hours post 
cocaine exposure. 
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Figure 3-2. Comparisons of Various Acute Time Points for SAPAPs 1 through 4 
in the Dorsal and Ventral mPFC.  
When all time points for a SAPAP/brain region are compiled and Compared to time 
matched cocaine naïve controls, SAPAPs display significant reductions at various time 
points after acute exposure (indicated by “*”). Significant reductions are observed only at 
8hr post-exposure in the ventral mPFC. In the dorsal mPFC, this compilation displays 
significant reductions in SAPAP2 levels at the 2, 4, and 8 hours post exposure. For all 
experimental groups, n = 4. 
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Table 3-1. Acute SAPAP Changes in Areas Other Than the mPFC. 
 
Area SAPAP Significant? Time points affected-(F, p) 
Nacc-CORE 1 No None 
 2 Yes 2 Hours (3.911, 0.0079) 
3 Yes 2 Hours (2.989, 0.0244) 
4 Yes 2 Hours (3.654, 0.0079) 
Nacc-SHELL 1 No None 
 
2 Yes 2 Hours (3.195, 0.0187) 
3 No None 
4 Yes 2 Hours (6.211, 0.0008) 
STRIATUM 1 No None 
 
2 No None 
3 Yes 2 Hours (5.261, 0.0019) 
12 hours (3.419, 0.0142) 
4 No None 
SUBSTANCIA 
NIGRA 
1 No None 
 
2 No None 
3 Yes 2 Hours (6.308, 0.0003) 
4 No None 
VENTRAL 
TEGMENTAL 
1 No None 
AREA 2 No None 
3 No None 
4 No None 
 
 
 
 
 
 
  
 34 
The next set of experiments involved sensitized animals. After pretreatment, 
animals were verified to be sensitized using previously established protocols. Cocaine 
injected animals displaying sensitized locomotor responses over saline controls  
(Figure 3-3). For animals at 2-weeks and 1 day post-withdrawal, no significant 
differences were observed for any SAPAPs for any of the examined regions, or any 
differences between treatment groups  
 
At the 3 week time point, a generalized statistically significant decrease was 
observed for SAPAPs 1-4 in the dorsal medial prefrontal cortex (Figure 3-4). In the 
dorsal mPFC, SAPAP1 was significantly decreased (F=6.793, df= 19, p= 0.0036) in all 
cocaine-exposed animals, compared to saline/saline animals (saline during daily 
treatments/saline on test day) that was even further reduced in cocaine sensitized animals 
receiving cocaine on test day (cocaine/cocaine). SAPAP1 was also decreased 
significantly (F=6.793 , df= 19, p= 0.0036) for saline controls receiving cocaine on test 
day and sensitized animals receiving saline on test day, with even lower SAPAP levels 
observed in sensitized animals exposed to cocaine on test day. SAPAP2 was decreased 
significantly (F= 3.800, df= 19, p= .0312) in sensitized animals exposed to cocaine on 
test day when compared to cocaine naïve controls. SAPAP3 was decreased significantly 
(F= 5.201, df= 19, p= .0107) in sensitized animals receiving cocaine on test day when 
compared to cocaine-naïve animals. SAPAP4 was decreased significantly (F= 7.421, df= 
19, p= .0028) in all sensitized animals receiving cocaine on test day with even lower 
SAPAP levels observed in sensitized animals exposed to cocaine on test day. No 
significant differences were noted for SAPAPs in the ventral mPFC for this time point, 
all with ps > .05.  
  
For our self-administration studies, all test and yoked animals maintained catheter 
patency throughout the entire experiment, and did not display injuries or infections before 
tissue harvesting. For test animals over the 10 day test period, significant or trending 
results were not observed for any of parameters of self-administration. SAPAP protein 
levels for test animals were observed to be significantly higher in both regions of the 
mPFC and Nacc core when compared to saline yoked control animals. In the dorsal 
mPFC (Figure 3-5A to H) significant increases in SAPAP levels of test animals were 
observed for SAPAP1 (t=4.173,df= 6, p= 0.0059, Figure 3-5A), SAPAP2 (t=3.909, df= 
6, p= 0.0079, Figure 3-5B), SAPAP3 (t=8.537, df= 6,  p= 0.0001, Figure 3-5C), and 
SAPAP4 (t=3.502, df= 6,  p= 0.0128, Figure 3-5D). In the ventral mPFC (Figure 3-5E) 
significant increases in SAPAP3 were observed (t=2.756, df= 6, p= 0.0330). In the Nacc 
core (Figure 3-5F and G) significant increases in SAPAP levels of test animals were 
observed for SAPAP2 (t=2.557, df= 6, p= 0.0431, Figure 3-5F) and SAPAP4 (t=4.618, 
df= 6, p= 0.0036, Figure 3-5G).  
 
 
Discussion 
 
When examining the time course of SAPAP changes in acutely exposed animals 
at many time points shorter than 24 hours, many significant SAPAP changes are found.  
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Figure 3-3. Sensitization Verification by Infrared Home Cage Monitors. 
Testing included a 1 hr activity baseline, followed by a 2 hr activity recording that was 
immediately preceded by a challenge dose of 15 mg/kg cocaine I.P. injection. These 
results show a significant increase in photocell counts for sensitized animals receiving a 
challenge dose of cocaine over drug naïve control animals. For both experimental groups, 
n = 16. For sensitized animals, “*” indicates a significant change when compared to 
cocaine naïve animals. 
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Figure 3-4. Varied SAPAP Reduction in Dorsal mPFC at 3 Weeks. 
SAPAP levels in the dorsal mPFC are universally down regulated in response to cocaine 
exposure, although the statistical significance and pattern of this down regulation varies. 
SAPAP1 (upper left, A), is decreased in similar fashion in cocaine naïve animals acutely 
exposed to drugs on test day and animals completely abstinent for 3 weeks, although an 
acute dose drive SAPAP1 levels even lower. SAPAP2 (upper right, B) are only 
significantly decrease in sensitized animals exposed to drug after 3-weeks on test day, 
which is similar in fashion to SAPAP3 levels (lower left, C). SAPAP4 levels in the 
mPFC (lower right, D) are statistically lower only in sensitized animals; levels are lower 
in animals receive cocaine on test day than animals experiencing a 3-week withdrawal, 
compared to cocaine naïve controls. Unaltered representative blot images are shown in 
panel E. For all experimental groups, n = 4. For all panels, “*” indicates a significant 
change from saline naïve animals, and “+” indicates a significant change from acutely 
exposed saline animals. 
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Figure 3-5. SAPAP Levels of the Dorsal mPFC Are Elevated for All SAPAPs in 
Test Self-Administration Rats. 
Protein levels for SAPAP1 (upper left, A), SAPAP2 (upper right, B) SAPAP3 (lower left, 
C), and SAPAP4 (lower right, D) in the dorsal mPFC are significantly increased for test 
animals self-administering cocaine (.3mg/kg/infusion) when compared to yoked cocaine 
naïve controls receiving saline. SAPAP3 levels (middle, E) are increased in the ventral 
mPFC of test animals self-administering cocaine (.3mg/kg/infusion) when compared to 
yoked cocaine naïve controls receiving saline. In the Nacc core of these same animals, a 
similar significant increase in SAPAP2 (bottom left, F) and SAPAP4 (bottom right, G). 
For all experimental groups, n = 4. For all panels, “*” indicates a significant change from 
yoked animals. 
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3 week abstinence period following cocaine self 
administration 
  
  
 
 
 
 
  
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
m P F C -D o r S A P A P 1
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
m P F C -D o r S A P A P 2
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
m P F C -D o r S A P A P 3
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
m P F C -D o r S A P A P 4
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
C o
n t
ro
l (
c o
k e
)
0 .0
0 .5
1 .0
1 .5
m P F C -V e n S A P A P 3
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
N A c c -C o re S A P A P 2
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
Y o
k e
d
(S
a l
in
e )
T e
s t
(c
o c
a i
n e
)
0 .0
0 .5
1 .0
1 .5
N A c c -C o re S A P A P 4
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
*
E.) 
G.) F.) 
B.) A.) 
C.) D.) 
 39 
These changes occur in most regions examined, and in most cases are not significant at 
24 hours after an acute dose of cocaine. This indicates that while far reaching, these 
changes along with their effects may be transient. Yet, in sensitized animals a particular 
subset of alterations becomes permanent. Interestingly, the striatum, substantia nigra, and 
VTA are not altered in the sensitization process, and in acute animals these regions 
display a significant elevation in certain SAPAPs. In contrast to the general SAPAP 
levels in these acutely and non-contingently exposed animals, cocaine-naïve animals that 
are acutely exposed to cocaine after 10 days of self-administration display universally 
elevated SAPAP levels. Although these changes may also be transient, significant 
SAPAP changes involve regions that are critical to maintenance of cocaine sensitization. 
In the dorsal prefrontal cortex, all 4 SAPAPs are significantly increased, while in the 
ventral mPFC only SAPAP3 is increased. For the self-administration experiments, the 
Nacc core of test animals also displays a significant increase in SAPAP 2 and SAPAP 4. 
 
For all other brain regions examined for all SAPAPs at the 1 day/2-weeks post 
abstinence time point, no statistically significant changes were observed. Differing from 
this pattern, results at 3-weeks post sensitization time point were predicted to yield the 
most changes in SAPAPs, as sensitization related molecular changes tend to be more 
exaggerated for the 3 week time period (expression phase) when compared to early time 
periods (initiation phase) [154]. Significant changes for the 1 day and 2 week time point 
yield no significant results (data not shown). However, at the 3 week time point, SAPAP 
reduction occurred in a variety of patterns for SAPAPs examined in the dorsal prefrontal 
cortex, along with a more consistent pattern of SAPAP protein deficiency observed in the 
Nacc core. This may be explained by the finding that at 3 week of cocaine abstinence 
after the last daily injection to induce sensitization, the sensitized locomotion displayed 
by sensitized animals in response to cocaine can be mimicked by AMPA injections into 
the Nacc core [155]. This effect is not due to AMPA-induced dopamine release [155].  
As AMPA is an artificial agonist that stimulates a specific class of ionotropic glutamate 
receptor, endogenous glutamate released in this region would also stimulate NMDA-type 
receptors, which removes SAPAPs from the synapse [138]. In the dorsal mPFC, all 
SAPAPs were significantly reduced in animals sensitized to cocaine and acutely exposed 
on test day. Moreover, for all time points, while the ventral prefrontal cortex, nucleus 
accumbens shell, dorsal striatum, substantia nigra, and ventral tegmental area were 
examined for all 4 SAPAPs, no other areas displayed statistically significant differences.  
 
The decrease in SAPAP levels for the majority of brain regions is a promising 
step in determining that extent of the molecular changes that occur in long-term cocaine 
abuse, and a possible mechanism to explain the compulsivity associated with cocaine 
addiction. Considering that SAPAPs are scaffolding proteins that help traffic NMDA 
receptors and PSD-95 to the synapse, these results may help explain why either NMDA 
receptor number or functionality are affected, as the absence of these proteins (especially 
acutely) could thwart efficient intracellular signaling. Indeed, the same publication that 
found SAPAP3 deletion is sufficient to cause compulsive grooming also reported that the 
same mice showed defects in neurotransmission, specifically reduced post synaptic field 
potentials of NMDA receptors [89]. Although our results reported here do not attempt to 
test physiology in any way, the loss of SAPAPs, with their role in facilitating clustering 
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of NMDA receptors, may help to further explain the glutamatergic disturbances in the 
sensitized brain [84]. Additionally, in the 3-week abstinence cohort, the results of the 
significant decrease of SAPAP protein in both the dorsal mPFC as well as the Nacc core 
fit comfortably in a larger context of addiction circuitry, as the dorsal mPFC specifically 
innervates the Nacc core, while enhanced behavioral sensitization is associated with 
enhanced glutamate transmission to this region [156]. Considering that cocaine 
sensitization results in increased glutamate transmission, the finding that SAPAP levels 
tend to be decreased also with cocaine exposure is not surprising. This is because 
excitation is known to remove SAPAPs from the synaptic density [138]. Moreover, the 
lack of significant SAPAP alterations at the 2-week and 1-day time points was partially 
expected, as certain facets of behavioral sensitization caused by altered glutamate 
transmission may simply require a longer incubation period to occur than examined here. 
This process continues to develop for up to 2 months in rats [157], and perhaps up to a 
full year in humans exposed to psychostimulants [158].  
 
Indeed, this extended time course of glutamatergic changes may partially account 
for the SAPAP changes we found in rats responding for cocaine. In these animals, for all 
significantly altered regions SAPAPs are universally elevated over cocaine naïve yoked 
controls. Although cocaine sensitized animals acutely exposed on test day display slightly 
lower protein levels, SAPAP levels in acutely exposed controls or sensitized animals 
unexposed on test day are slightly higher. While not definitive, these results may indicate 
that short incubation time following acute exposure to cocaine may result in increased 
SAPAP levels.  Moreover, the finding that all SAPAPs in the dorsal mPFC and dendritic 
SAPAP3 in the ventral mPFC are altered may reflect the unequal roles of these regions in 
the sensitization process, as changes occur early in the dorsal mPFC and later in the 
ventral mPFC as cocaine exposure progresses from acute to chronic.  
 
For future experiments addressing our results, we will extend these studies to a 
later time point, and examining if protein localization is affected in cocaine 
sensitized/exposed rats. This may yield additional data into how sensitization affects 
SAPAP levels. We also hope to use viral constructs to knockdown SAPAP mRNA 
expression in the key regions studies, to determine if this alone would have any effect on 
the behavioral aspects of sensitization. However, if not by conducted by our group, 
molecular studies into the exact roles of SAPAPs would greatly enhanced the impact of 
this and any future experiments as the intimate details of the role of this protein family 
are largely a mystery. Part of this mystery includes the lack of a mechanism to explain 
why this occurs. One possible theory is that mechanism controlling SAPAP levels may 
also include proteins that regulate gene expression. Cocaine can selectively activate class 
II activity-dependent histone deacetylases (HDACs), especially HDAC5. When activated 
exposing normally inactivated regions of chromatin to the possibility of transcription 
[159]. This is not a very abstract line of thought. HDAC5-deficient mice show a strong 
preference for the rewarding effects of cocaine in a conditioned place preference 
paradigm (which is rescued by viral transfection of full-length native HDAC5), and that 
HDAC5 is associated with enhanced cocaine responses [159]. To confirm this theory, 
brain tissue of animals confirmed to be sensitized could also be probed for H3K9/14Ac, 
and H4K5/8/12/16Ac, known markers of transcription activation [160].   
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CHAPTER 4.    SENSITIZATION-INDUCED CHANGES OF AMPA/NMDA 
RECEPTOR RATIO IN THE MPFC 
 
 
Rationale 
 
Population changes of ionotropic AMPA/NMDA glutamate receptors are critical 
to the initiation and maintenance of cocaine sensitization. In response to cocaine 
sensitization, these changes have been reported to be enduring in the nucleus accumbens 
(Nacc), transient in the ventral tegmental area (VTA), and currently unreported in a 
region known to be dysfunctional in cocaine addicts, the medial prefrontal cortex 
(mPFC). Here, we examined the effects of cocaine sensitization and acute cocaine 
exposure on the AMPA/NMDA receptor pool in the dorsal and ventral mPFC. Rats were 
sensitized to cocaine over 4 days (15 mg/kg/day) and along with time-matched sham-
injected controls, exposed to an acute dose or saline injection after a 1 day, 2 weeks, or 3 
weeks cocaine abstinence period. Using this paradigm, several acute and sensitization-
related changes were observed. After 2-weeks of abstinence, changes uncovered included 
a decrease in dorsal GluR1 subunits, an increase in ventral intracellular GluR2 subunit, 
and a decrease in intracellular NR1 subunits. At 3 weeks of abstinence, significant 
receptor changes were restricted to the ventral mPFC, and consisted of a significant 
increase in GluR2 and NR2B surface subunits in sensitized animals. These results will 
broaden our understanding of how glutamate transmission is affected by acute cocaine 
exposure and cocaine sensitization.  
 
 
Background 
 
In comparison to dopamine, glutamate has proven to be a vital, yet often upstaged 
actor in the interplay of the neurotransmitters that contribute to cocaine sensitization. In 
cocaine users, many symptoms associated with long-term cocaine use can be directly 
traced to altered glutamate transmission. Evidence implicating glutamate has been found 
in live addicts [161] and cadaver tissue [162], with much of the data collected in clinical 
settings being confirmed in animal models [163]. Live brain imaging indicates decreased 
prefrontal activity as well as decreased prefrontal glutamate levels in cocaine addicts 
even after periods of abstinence [71]. Furthermore, severing the glutamatergic projections 
from the medial prefrontal cortex (mPFC) in rats [164] or selective blockade of excitatory 
glutamate receptors [165] will halt the expression of any previously established 
behavioral sensitization. In humans, changes in glutamate receptors are thought to be 
responsible for the escalation of drug use that demarcates recreational and habitual use 
[166]. Moreover, long-term chronic cocaine use is thought to result in behavioral 
sensitization, a disorder marked by cocaine induced psychosis [167], paranoid 
behavior[168], seemingly useless repetitive movements [169], intrusive/unwanted 
thoughts about drugs/drug cravings [170], and relapse even after a long period of healthy 
sobriety [170]. Although these effects are thought to stem from changes in prefrontal 
glutamate, the mechanisms of how the populations of AMPA/NMDA ionotropic 
glutamate receptors (iGluRs) are affected in this region is currently a mystery. Despite 
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this, it is known that the end result of cocaine-induced changes in the mPFC creates a 
region hyper-excitable to glutamate, indicating that there may be an increase in the 
contribution of excitatory AMPA receptors [171]. This enhanced response to glutamate in 
not solely restricted to the mPFC, and thus the study of other regions of this 
mesocorticolimbic system may reveal how glutamate receptors are altered in this region. 
 
Considering that individual brain regions work as a circuit to control behavior, it 
is reasonable that the process of altered glutamate transmission in the mPFC is initiated 
elsewhere. In response to cocaine sensitization, both the “core” and more lateral “shell” 
of the Nacc display an abnormally high synapse-to-neuron ratio [172]. These extra 
synapses are the result of structurally abnormalities that include increased dendritic 
spines, dendrites with multiple spines, longer than average dendrites, and dendrites that 
inappropriately “boundary cross” into adjacent nuclei [76]. This underlying structural 
remodeling in the Nacc core ultimately influences the physiology of the Nacc, and is 
initiated by NMDA receptors [77]. The Nacc Core occupies a critical junction in the 
mesocorticolimbic system as there is a direct connection between it and the dorsal portion 
of the mPFC where critical exchanges of neurotransmitter innervations occur.  
 
In response to cocaine at this critical junction, a series of events follows that is 
critical to the development of behavioral sensitization. In response to repeated cocaine 
exposure, dopamine release in the mPFC is reduced [173] and results in behaviors 
reminiscent of those observed in cocaine sensitized animals [174]. Glutamate levels in 
the mPFC are concurrently elevated, and glutamate antagonist in the mPFC will prevent 
sensitization [175]. Moreover, although cocaine sensitization affects the mPFC as a 
whole, the dorsal and ventral regions are affected differently by cocaine sensitization. 
The dorsal mPFC is preferentially affected in response to acute cocaine, and lesioning 
this area will prevent the initiation and expression of sensitization from occurring [147]. 
Conversely, administering the GABA agonist baclofen in the ventral mPFC will prevent 
acute cocaine-induced motor activity and initiation of sensitization, but not its expression 
[148].  
 
Considering that both the Nacc and mPFC show enhanced excitability to 
glutamate, underlying mechanisms within these two regions may be similar. Although 
unknown for the mPFC, the manner in which glutamate receptors are altered in the Nacc 
is well documented for fast-acting ionotropic glutamate receptors (iGluRs). These 
receptors directly affect current influx, while slower-acting metabotropic glutamate 
receptors (mGluRs) moderate neuron-wide responses and iGluRs activity [176]. 
Sensitization-induced glutamate sensitivity in the Nacc occurs due to an increased 
contribution of Ca2+ permeable AMPA receptors (CP-AMPARs) [177]. This effect is 
also concurrently associated with a decreased contribution of LTP-inhibiting mGlur1 and 
NMDA receptors [178, 179]. NMDA receptors themselves are reduced in response to 
psychostimulant withdrawal in the Nacc [180], with the resulting AMPA-dominant 
current contributing to the incubation of craving and vulnerability to cue-induced relapse. 
This AMPA current is also associated with increased expression, total input strength, and 
accumulation of CP-AMPARs [181]. In addition to these effects on iGluRs, the ability of 
mGluR1 to mediate LTD is decreased in the Nacc. Considering this, not only does 
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receptor content influence output from nuclei/subnuclei, but output may also be 
influenced by subunit composition of these receptors. This is because subunit 
composition determines whole-receptor function. For example, CI-AMPARs lose their 
permeability to calcium through inclusion of GluR2 [182]. NMDA receptors require the 
NR1 subunit as a necessary component to generate typical NMDA-specific currents 
[183], and have NR2 subunits with cell-type specific intracellular C-terminal domains 
that alter channel kinetics [184]. The activity-dependent ratio of NR2A/NR2B is vital to 
cortical functioning [185], and in response to increased activation of NMDA receptors, 
NR2A subunits are decreased concurrently with receptor activity [186] (an effect that is 
Ca2+ dependent [187]). These subunits can also be increased by blockade of iGluRs 
and/or cell activity [188], indicating that down-regulation of these subunits may be 
protective against the harmful effects of increased glutamatergic transmission. NR2B 
subunits do not appear to be dynamically regulated, and although NR2A/B ratio is 
critical, this ratio appears to be solely regulated through NR2A-subunit alterations [188]. 
Considering that NR2A/B are expressed at their highest levels in the cerebral cortex [70], 
it stands to reason that sensitization-induced iGlurR population changes may have a 
significant role in the mPFC. 
 
Taken these studies of the mPFC and Nacc together, a model emerges that adds a 
functional context to the consequences of modifications to the mesocorticolimbic circuit 
in response to cocaine sensitization. In this model, dramatic yet transient changes occur 
in the VTA that increase the dopaminergic tone onto the Nacc. Glutamate receptor 
changes result in a regional hyper excitability due to an increased contribution of Ca2+-
permeable AMPA receptors, but also a lack of glutamatergic braking ability due a 
decreased contribution of mGlur1 and NMDA receptors. Taking these facts into account 
along with studies that show decreased activity [71] as well as decreased prefrontal 
glutamate levels in the prefrontal cortex of cocaine addicts even after abstinence indicate 
that glutamate receptors could play a vital role in the long term expression. We believe 
this is region ripe for investigation, and here we propose to investigate if behavioral 
sensitization to cocaine results in changes of whole surface AMPA/NMDA receptor and 
receptor subunit populations in the mPFC, and the time course of any changes. 
 
 
Methods 
 
 
Animal Subjects 
 
48 male albino Sprague Dawley rats weighing approximately 250g on arrival 
were acclimated to reversed light cycle housing (LIGHTS OFF - 05:00-18:00 hrs, 
LIGHTS ON- 18:00-05:00 hrs) for 3 days, and were housed individually for the duration 
of their lives. Rats were sensitized by receiving an injection of cocaine (15 mg/kg) once a 
day at 12:00-13:00 for 4 days. A separate group control animals received sham (saline) 
injections on the same schedule as sensitized test animals. Next, both groups of animals 
were divided into 3 cohorts that underwent a period of abstinence for 1 day, 14 days, or 
21 days (food/water free-feeding). On the day following the abstinence period, sensitized 
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animals were tested alongside time-matched and sham-injected control rats for any 
enhanced drug induced locomotion in infrared home cage monitors (Accuscan 
Instruments Inc.). A baseline measure of motor activity was obtained for 1 hr, and then 
sensitized animals either were challenged with a dose of 15 mg/kg I.P. cocaine 
(cocaine/cocaine group) or received a sham injection of saline (cocaine/saline group). 
Cocaine naïve controls were examined alongside sensitized animals, and either received a 
single injection of cocaine on test day (saline/ cocaine group) or another injection of 
saline (saline/saline). Regardless of the injection administered, the challenge session was 
concluded after 2 hr. Immediately following the end of the challenge session, rats were 
anaesthetized in a sealed gas chamber by introduction of pure CO2 for 10 sec and 
immediately sacrificed by guillotine.  
 
 
Tissue Harvesting and Crosslinking 
 
After removal, the brain was placed on ice then dissected for the medial prefrontal 
cortex (mPFC, dorsal and ventral regions separated), using established protocols [151]. 
Immediately after the removal of each brain region using ice-cold instruments without 
freezing the brain tissue before dissection, specimens were manually “diced” into pieces. 
All samples cut consistently in approximately the same manner and size for each animal. 
Sample pieces were placed in freshly prepared, ice-cold artificial cerebrospinal fluid (1.2 
mM CaCl2, 20 mM HEPES-pH 7.4, 0.147 M NaCl, 2.7 mM KCl, 1 mM MgCl2, 100 
mM Dextrose) spiked with 52 mM bis-sulfosuccinimidyl suberate (BS3) immediately 
before the addition of tissue to cross-link surface AMPA/NMDA receptors. Next, 
samples were left to agitate at 4° C for 30 minutes, and after this period sample tubes 
were next spiked with 100 ul of 1 M glycine solution to quench BS3, and incubated for 
an additional 10 minutes at 4° C. After incubation, all samples were centrifuged for 2 min 
at 20,000 X g. The supernatant was then discarded. Less than 3 min elapsed from 
guillotining to sample incubation in artificial cerebrospinal fluid. For longer term storage, 
samples were stored at -80° C.  
 
 
Protein Sample Preparation and Immunoblotting 
 
Whole tissue samples were sonicated in 2% SDS and centrifuged at 13,000 X g 
for 30 sec. To obtain the protein concentration of the sample, 200 μl of this whole tissue 
sample preparation was analyzed in triplicate using a Bio-Rad® DC™ Protein Assay Kit. 
The triplicate readings were average together, and this average was used as the protein 
concentration. An aliquot of tissue sample was diluted to 2.0 μg protein/μl with 2% SDS. 
An aliquot of this diluent was diluted to 1 μg protein/μl with an equal volume of 2x 
electrophoresis sample buffer [final concentration after dilution=50 mM Tris HCl (pH 
6.7), 4% glycerol (wt/vol), 2% SDS, 5 mM dithiothreitol and bromophenol blue (0.01 
mg/ml)].  Proteins (20 μg/lane) were separated by size on a 10% SDS-polyacrylamide gel 
transferred to Immobilon-P PVDF transfer membranes (Millipore) in Towbin’s-SDS 
transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol, and 0.01% SDS) at 120V, 
0.35 A for 2 hrs at room temperature with the transfer apparatus packed in ice. After 
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transfer, the membrane was removed from the transfer apparatus, was left to dry 
overnight at room temperature. 
 
Membranes were reactivated after 12 hrs using 1x 20 sec methanol wash, 
followed by 2x 30 sec wash in ddH20, 1x 10 min wash in ddH20, and 1x 15 min wash in 
TBST. Membranes were blocked in TBST containing 5% nonfat dried milk (NFDM 
Blotting Grade Blocker, Bio-Rad) for 1 h at room temperature with agitation. The 
membrane was washed once with TBST for 5 min and incubated with the primary 
antibody (subunits GluR1, GluR2, NR1, NR2A, and NR2B obtained from Sigma-Aldrich 
Company, St. Louis MO) diluted to 1:20,000 in TBST containing 0.5% NFDM for 1 h. 
As an experimental control, all throughout the labeling process, another portion of each 
corresponding membrane was concurrently probed with an anti-beta tubulin antibody 
(Sigma Aldrich). The membranes were then washed once for 15 min and twice more for 
5 min in TBST followed by a 1 hr incubation with agitation at room temperature with 
horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Pro-Sci) diluted 
1:5000 in TBST containing 0.5% NFDM. After this incubation, the membranes were 
washed as above and the antigen-antibody-peroxidase complex was detected by enhanced 
chemiluminescence (West Femto Substrate, Thermo Scientific) according to the 
manufacturer’s instructions and visualized, analyzed and quantified by computer-assisted 
densitometry using a Bio-Rad Molecular Imaging System using Quantity One Imaging 
Software. After visualizing, the membranes were then stripped using 0.1M glycine 
stripping buffer (pH=2.2) containing 1% (v/v) Tween-20.  
 
 
Analysis 
 
For each subunit or beta tubulin band, the band area was measured and using the 
imaging software, its adjusted percent volume was calculated, globally subtracting any 
background present. For each subunit band, adjusted percent volume value was then 
divided by its corresponding beta tubulin value using Microsoft Excel for each sample 
lane. External whole receptors were measured as the top band observed to not run into the 
lower separating gel, and internal subunits as bands small enough to run into the stacking 
gel, ranging in size from approximately 80-130 kDa.  All statistical calculations were 
performed using Prism (Version 5, Graphpad Software Inc.) one-way ANOVA analysis 
(Newman-Keuls multiple comparison post-test) 
 
 
Results 
 
After pretreatment, animals were verified to be sensitized using previously 
established protocols (t= 5.492, df= 30, p= < 0.0001, Figure 4-1). Subunits examined for 
NMDA receptors consisted of NR2A, NR2B, and NR1.  The NR1 subunit is a necessary 
subunit for NMDA receptors, and any changes associated with this subunit were 
considered to represent a change in PSD receptor numbers. Subunits examined for 
AMPA receptors consisted of GluR1 and GluR2.  The GluR1 subunit is a necessary 
subunit for AMPA receptors, and any changes associated with this subunit were  
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Figure 4-1. Sensitization Verification by Infrared Home Cage Monitors. 
Testing included a 1 hr activity baseline, followed by a 2 hr activity recording that was 
immediately preceded by a challenge dose of 15 mg/kg cocaine I.P. injection. These 
results show a significant increase in photocell counts for sensitized animals receiving a 
challenge dose of cocaine over drug naïve control animals. For both experimental groups, 
n = 16. For sensitized animals, “*” indicates a significant change when compared to 
cocaine naïve animals. 
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considered to represent a change in PSD receptor numbers. Significant receptor changes 
for either AMPA or NMDA receptors, as well as subunits, are not present for any 
treatment group at 1 day of withdrawal after sensitization injections and subsequent 
verification, with zero trending results, and wide inter/intra treatment group variances 
noted (data not shown: p > 0.05). 
 
AMPA receptor subunits were also examined at 2 and 3 weeks of abstinence. For 
AMPA receptor subunits at 2 weeks post withdrawal compared to cocaine-naïve controls, 
a significant reduction for GluR1 subunits was observed in the dorsal mPFC for the 
intracellular and extracellular fractions. In the intracellular fraction, significant 
differences were observed for saline/saline vs. saline/cocaine, saline/saline vs. 
cocaine/saline, and saline/saline vs. cocaine/cocaine (F= 10.88, df=15, p= 0.0010,  
Figure 4-2A). Sensitized animals acutely exposed on test day displayed further reduction 
in GluR1 when compared to the saline/cocaine group and the cocaine/saline group. In the 
extracellular fraction (F= 20.65, df= 15, p= < 0.0001, Figure 4-2B), significant 
differences were observed for saline/saline vs. saline/cocaine, saline/saline vs. 
cocaine/saline, and saline/saline vs. cocaine/cocaine. Sensitized animals acutely exposed 
on test day displayed further reduction in GluR1 when compared to the saline/cocaine 
group and the cocaine/saline group. The ventral mPFC displayed no significant changes 
in GluR1 for this time period in expressed receptors or internal subunits (data not shown, 
p > .05). For both fractions of the dorsal mPFC, GluR2 subunits were insignificantly 
altered for this time point (data not shown, p > .05), and for the external fraction of for 
the ventral mPFC (Figure 4-2D). For the internal subunits of GluR2 in the ventral mPFC, 
GluR2 subunits are significantly elevated with significant differences observed for 
saline/saline vs. saline/cocaine, saline/saline vs. cocaine/saline, and saline/saline vs. 
cocaine/cocaine (F=29.02, df= 15, p= >.0001, Figure 4-2C). Sensitized animals 
regardless of exposure on test day also displayed an increase in GluR2 when compared to 
the saline/cocaine group, for the cocaine/saline group and the cocaine/cocaine group. At 
the 3-week withdrawal time point, a significant elevation surface GluR2 subunits was 
observed for the cocaine/saline and cocaine/cocaine groups when compared the drug 
naïve controls (F=3.521, df= 23, p= 0.0339, Figure 4-3). 
 
Concerning NMDA receptors at 2 weeks withdrawal, while no significant 
changes were recorded for the dorsal mPFC in NR1 levels (data not shown), we observed 
a significant reduction of NR1 subunit in the internal fraction of the ventral mPFC 
(F=14.62, df= 15, p= 0.0003, Figure 4-4A). When compared to naïve controls, 
significant differences are observed for the saline/cocaine group and cocaine/saline 
group, but not for the cocaine/cocaine group. No significant differences were observed 
for the surface fraction (Figure 4-4B). For the NR2A subunit at 2 weeks of abstinence, 
results followed similar patterns in both the dorsal and ventral mPFC, although 
statistically significant changes were only found in the ventral mPFC. For the internal 
fraction, a significant elevation in NR2A levels was observed with comparable 
differences for the saline/cocaine group and cocaine/saline group when compared to 
naïve controls (F=11.21, df= 15, p= 0.0009, Figure 4-4C). Conversely, there was a 
significant reduction in NR2A in sensitized animals acutely exposed on test day when 
compared to the saline/cocaine group and the cocaine/saline group. Results were similar  
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Figure 4-2. AMPA Receptor Changes at 2-Weeks. 
Significant reductions GluR1 subunits are observed in the dorsal mPFC for both the 
intracellular (A, upper left) and extracellular (B, upper right)  fractions, with the highest 
levels being observed in cocaine naïve controls, and the lowest levels in sensitized 
controls exposed on test day. For the intracellular (C, bottom) fraction of GluR2 in the 
ventral mPFC, surface expression is significantly elevated in all animals exposed to 
cocaine, with the highest levels found in sensitized animals, and although internalized 
receptor display this same trend, results are not significant. For all experimental groups, n 
= 4. For all panels, “*” indicates a significant change from cocaine naïve animals, and 
“+” indicates a significant change from acutely exposed saline animals, and “#” indicates 
a significant change from sensitized animals that received saline on test day. 
Representative blots are located under each set of panels, with the dotted line 
representing the running/stacking gel interface that separates the upper surface fraction 
from the lower intercellular fraction.  
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Figure 4-3. GluR2 Subunit Changes in the Ventral mPFC at 3-Weeks. 
While a variety of iGluR modification were uncovered at the 2-week time point, 
significant changes a week later appear to be restricted to the extracellular fraction of the 
ventral mPFC, and consist of a significant increase in GluR2-containing AMPA receptors 
in sensitized animals regardless of challenge dose, over cocaine naïve controls. Note that 
“*” indicates a significant change from cocaine naive animals. Representative blot 
images are located under the panel, with the dotted line representing the running/stacking 
gel interface that separates the upper surface fraction from the lower intercellular fraction 
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Figure 4-4. NR1 and NR2A Subunit Changes at 2-Weeks. 
Significant alterations in internal NR1 subunits (A, upper left) for the ventral mPFC is 
noted, with a significant elevation over completely cocaine naïve controls observed in 
control animal exposed to a cocaine challenge on test day. However, NR1 levels decrease 
as cocaine exposure increases, with the lowest intracellular NR1 levels in cocaine 
sensitized animals exposure to cocaine on test day. Surface subunit expression in this 
region (B, upper right) follows oppositely trends, albeit none significantly. NR1 levels 
are in general decreased as cocaine exposure increases, yet the highest surface expression 
levels by far are observed in sensitized animals receiving drug on test day. The 
intracellular NR2A subunit fraction in the ventral mPFC (C, bottom) follows a similar 
patterns as in the dorsal mPFC.  Protein levels increase in controls animals exposed to 
drug on test day over completely drug naïve animals. Yet, levels decrease in sensitized 
animals completely abstinent for 2 weeks, and even further in sensitized subjects 
receiving drug on test day. For all panels, “*” indicates a significant change from cocaine 
naive animals, and “+” indicates a significant change from acutely exposed saline 
animals, and “#” indicates a significant change from sensitized animals that received 
saline on test day. Representative blots are located under each set of panels, with the 
dotted line representing the running/stacking gel interface that separates the upper surface 
fraction from the lower intercellular fraction.  
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for the external fraction, with a significant elevation observed when compared to cocaine 
naïve animals for the saline/cocaine group and the cocaine/saline group (F=10.94, df= 15, 
p= 0.0009, Figure 4-5). This result was also accompanied by a significant reduction in 
NR2A subunit when comparing to the saline/cocaine vs. cocaine/cocaine and 
cocaine/saline vs. cocaine/cocaine.  
 
For the NR2B subunit in the dorsal mPFC, significant results were found for the 
external fraction only when compared the control rats and sensitized rats acutely exposed 
on test day (F=3.390, df= 15, p= 0.0539, Figure 4-6A). Externally in the ventral mPFC, 
NR2B levels are lowered in the cocaine/cocaine group when compared to the 
saline/cocaine and cocaine/saline groups (F=7.209, df= 15, p= 0.0050, Figure 4-6C). 
Internally, results are significantly different when comparing saline/saline vs. 
cocaine/cocaine, saline/cocaine vs. cocaine/cocaine, and cocaine/saline vs. 
cocaine/cocaine (F=11.11, df= 15, p= 0.0009, Figure 4-6B). At the 3 week withdrawal 
time point, significant changes appear to be restricted to the extracellular fraction of the 
ventral mPFC, which displays a sensitization-specific subunit increase for the NR2B 
subunit (F=4.442, df= 23, p= 0.0151, Figure 4-7). For NR2B, sensitized animals acutely 
exposed display elevated external levels when compared to control animals acutely 
exposed on test day as well as drug naïve controls. 
 
 
Discussion 
 
While initially reviewing the time-course for the whole receptor and subunit 
changes, the lack of receptor changes observed at 1-day post withdrawal fits with 
previous studies from our lab. This would indicate early transient changes in 
neurotransmitter release, and delayed changes in receptor function. However, glutamate 
receptor changes are capable of occurring on a scale ranging from minutes to hours [189].  
 
These results could be influenced by our experimental design that specifies the 
sacrifice of animals at least 2 hours after exposure to a challenge dose of drug which 
would mask any very early receptor-centered effects of cocaine, effects of receptor 
phosphorylation that may precede removal or inclusion at the synapse [190], or that 
sensitization related changes may require more than 1 day post-withdrawal to begin to 
exert an effect on glutamate receptors. Also surprising was the finding that receptors in 
the prefrontal cortex in some control animals (completely cocaine naïve until given a 
challenge dose) begin to display acute prefrontal iGluR effects to drug, although it is not 
known if these effects are permanent or transient in nature. As sensitization changes 
continue to occur over the course of 3-weeks, more drastic changes in AMPA/NMDA 
receptor populations were expected as the time interval increased, yet a larger variety of 
changes appear to be observed at the 2-week withdrawal time-point instead of at the 3-
week time-point. Changes that are observed at 3-weeks post withdrawal affect sensitized 
animals similarly regardless of acute drug exposure which may possibly indicate an 
enhancement of long-term potentiation. This may be possible at 3-weeks, as LTP has 
been reported to occur in the mPFC of sensitized animals after 3-days of drug abstinence 
[191]. This study also suggested that these effects were caused by GABA(A) receptor  
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Figure 4-5. Surface NR2A Subunit Changes at 2-Weeks in the Ventral mPFC. 
Extracellular NR2A subunit fractions in the ventral mPFC follow similar patterns as in 
the dorsal mPFC.  Protein levels increase in controls animals exposed to drug on test day 
over completely drug naïve animals. Yet, levels decrease in sensitized animals 
completely abstinent for 2 weeks, and even further in sensitized subjects receiving drug 
on test day. Note that, “*” indicates a significant change from cocaine naive animals, and 
“+” indicates a significant change from acutely exposed saline animals. Representative 
blots are located under the panel, with the dotted line representing the running/stacking 
gel interface that separates the upper surface fraction from the lower intercellular 
fraction. 
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Figure 4-6. NR2B Subunit Changes at 2-Weeks. 
For NR2B subunits, significant results were only obtained for the surface fraction of the 
dorsal mPFC (A, top), as sensitized animals drug exposed on test day showed 
significantly lower levels than other treatment groups. In contrast to the NR2B in the 
dorsal mPFC, the ventral mPFC showed significant results in the surface (B, bottom left) 
and internal (C, bottom right), wherein significant results where only obtain for animals 
receiving drug on test day, an elevation in control animals and a reduction in sensitized 
animals over cocaine naïve controls. For all panels, “*” indicates a significant change 
from cocaine naive animals, “+” indicates a significant change from acutely exposed 
saline animals, and “#” indicates a significant change from sensitized animals that 
received saline on test day. Representative blots are located under each set of panels, with 
the dotted line representing the running/stacking gel interface that separates the upper 
surface fraction from the lower intercellular fraction. 
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Figure 4-7. NR2B Subunit Changes in the Ventral mPFC at 3-Weeks. 
While a variety of iGluR modification were uncovered at the 2-week time point, 
significant changes a week later appear to be restricted to the extracellular fraction of the 
ventral mPFC, and consist of a significant increase in NR2B-containing NMDA receptors 
in sensitized animals regardless of challenge dose, over cocaine naïve controls. Note that 
“*” indicates a significant change from cocaine naive animals. Representative blot 
images are located under the panel, with the dotted line representing the running/stacking 
gel interface that separates the upper surface fractions from the lower intercellular 
fraction. 
 
  
M P F C V e n N R 2 B E x C e ll
S a
lin
e -
S
S a
lin
e -
C
C o
k e
- S
C o
k e
- C
0 .0
0 .5
1 .0
T re a tm e n t G ro u p
G
lo
b
a
l%
A
d
ju
st
e
d
V
o
lu
m
e
S a lin e - S
S a lin e - C
C o k e - S
C o k e - C
* *
 
NR2B          
B-Tubulin   
 55 
blockade, which was later verified to occur in response to repeated cocaine exposure 
[192]. 
 
Despite these uncertainties, we may glean information on possible physiological 
functions through iGluR subunit alterations, albeit limited without corroborating 
electrophysiological studies. According to our data, at 1 day post-sensitization, changes 
are not present, yet by 2-weeks changes are evident in the iGluR receptor population.  At 
two weeks, animals exposed acutely to cocaine experience a reduction in GluR1 subunits 
in the dorsal mPFC that increases as cocaine exposure increases. Considering the 
concurrent increase in the ventral mPFC, these events may represent a compensatory 
mechanism against excessive glutamate transmission. Even without a concurrent 
elevation of NMDA receptors in the dorsal mPFC, this shift in the total ratio of iGluRs 
still has functional consequences, which may result in silent synapses, as NMDA-
receptor input overpowers that of AMPA receptors. In contrast to the dorsal mPFC, 
changes are present for NMDA receptor subunits the ventral mPFC, and consist of 
intracellular down regulation of NR1 subunits, and a decrease in NR2A/B subunits. This 
may indicate less net expression of NMDA receptors, and increased contribution of 
AMPA receptors. In the “big picture”, at 2-weeks, the documented changes may result in 
altered glutamate responses in the dorsal and ventral mPFC, which includes GluR2 
subunits to mute the enhanced AMPA currents. At 3-weeks, however, alterations in 
iGluRs are restricted to the ventral mPFC. While receptors number is unchanged, there is 
an increase in surface GluR2 and NR2B subunits that is present in sensitized animals 
regardless of an acute cocaine challenge. This indicates that not only are these longer-
term changes a fixture in sensitized animals, but that adaptations have occurred that 
reduce the excitability of AMPA receptors while increasing their impact due to decreased 
NMDAR contribution.  
 
These data fit the known results of sensitization in the dorsal and ventral mPFC, 
in that the expression of behavioral sensitization can be induced by lesioning the dorsal 
mPFC [147] and reversed by inhibition of the ventral mPFC [193]. This lesioning of the 
dorsal mPFC may replicate consequences of this enhanced glutamate transmission in the 
dorsal mPFC. Excessive glutamate transmission is fatal to cortical pyramidal neurons 
[194], and mPFC lesioned animals find cocaine more reinforcing over sham controls 
[195] and display a sensitized response to amphetamine [196]. This is supported by the 
finding that ventral mPFC neurons (which contains direct glutamatergic projections to the 
Nacc) seem to be more responsive to glutamate in response to cocaine exposure [197]. 
Although the current results are promising, future experiments would be well served to 
conduct imaging to determine how the population of modulating mGluRs is altered, the 
exact layers that are affected by the receptor changes, and functionality how these 
detailed receptor changes affect and contribute to the expression of behavioral 
sensitization.  
 
Our results in these two regions of the mPFC correspond to data published on the 
effect of mPFC cocaine exposure. In behavioral sensitization, cocaine induced changes 
occur initially in the dorsal mPFC when compared to those in the ventral mPFC. If the 
dorsal mPFC is lesioned, this process is thwarted and behavioral sensitization cannot 
 56 
occur. If not prevented in some form, the effects of increased glutamatergic transmission 
will eventually permanently alter the ventral mPFC. While GABA agonists can prevent 
the effects of enhanced glutamatergic transmission in the ventral mPFC caused by acute 
cocaine and the initiation of behavioral sensitization, they cannot reverse changes already 
present. This would explain why baclofen is ineffective in preventing the expression of 
behavioral sensitization. Reversing the effects of sensitization in the ventral mPFC can 
prevent behavior associated with sensitization. Understanding these physiological 
changes could be a key step toward understanding the persistence of sensitization. The 
maintenance of a delicate balance of neurotransmitter regulation to the basal ganglia (i.e. 
the nucleus accumbens) is critical for healthy brain function. Any shifts in this balance 
tend to produce pathology [198]. Following this logic, we gain an appreciation of not 
only possibly why altered glutamate transmission has long been associated with 
psychiatric/nervous system disease [199, 200], with abnormalities indicated for many 
disorders including Huntington’s Disease [201], schizophrenia [202], and bipolar 
disorder [203], and seemingly now cocaine addiction. These results not only advance the 
study of the underlying glutamatergic mechanisms responsible for cocaine sensitization, 
but may reveal clues of how glutamate is affected in all of these neurological diseases. 
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CHAPTER 5.    CONCLUSION 
 
 
 In summary, we conducted separate studies to examine the effects of cocaine 
sensitization. The first of these studies examined the effects of low-dose cocaine self-
administration in cocaine-sensitized animals, amphetamine-pretreated animals cross-
sensitized to cocaine, and non-sensitized sham-treated controls. A significantly higher 
number of psychostimulant-sensitized animals completed training when compared to 
non-sensitized sham-injected controls. While this has been reported to occur for higher 
doses of cocaine, this has not been reported to occur for a dose as low as 0.3 
mg/kg/infusion. For all of other parameters of self-administration examined, significant 
results were not found.  Reasons for this are not certain, although factors that affect 
responding under self-administration may include the speed of which the cocaine reward 
was administered, a resistance of saline controls to acquire self-administration, and self-
administration occurring in a different environment than drug injections. 
 
The second study examined the effects of acute cocaine exposure, cocaine 
sensitization and contingent cocaine exposure on SAPAP levels in the mesocorticolimbic 
circuit. Contingent cocaine exposure in sensitized animals generally results in increased 
SAPAP levels. These effects are transient, yet widespread and diverse in the regions and 
SAPAPs affected. Interestingly, non-contingently acutely exposed regions of the 
mesocorticolimbic circuit display a transient SAPAP decrease that generally recover to 
baseline levels 24 hrs after exposure. In addition to these effects observed at shorter time 
points, at 3 weeks of abstinence all SAPAPs in the dorsal mPFC were significantly 
reduced in animals sensitized to cocaine and acutely exposed on test day. For this time 
point in the Nacc core, all SAPAPs were decreased in a singular, consistent manner, with 
significantly lower levels observed in response to an acute dose on test day in sensitized 
animals. Moreover, for all withdrawal time points, while nucleus accumbens shell, dorsal 
striatum, substantia nigra, and ventral tegmental area were examined for all 4 SAPAPs, 
none of these areas displayed statistically significant differences. Differing from this 
pattern, at 2 weeks post-withdrawal in the dorsal mPFC SAPAPs 3 and 4 that decreased 
in cocaine-sensitized animals exposed to cocaine on test day. For our self-administration 
experiment in this study, SAPAP levels were altered in test animals responding under 
FR1 for cocaine rewards. SAPAP protein levels for test animals were observed to be 
significantly higher for all SAPAPs in the dorsal mPFC, SAPAP3 in the ventral mPFC, 
and SAPAPs 2 and 4 in the Nacc core. 
 
The third and final study examined the effects of cocaine sensitization and acute 
cocaine exposure on the AMPA/NMDA receptor population in the medial prefrontal 
cortex. Significant receptor subunit changes were not found for animals abstinent from 
cocaine for 1-day, which confirmed data for other studies from our research group. At 2 
weeks of cocaine abstinence, animals exposed acutely to cocaine experienced a reduction 
in GluR1 subunits in the dorsal mPFC in a fashion that increases as cocaine exposure 
increases, with a concurrent increase in the ventral mPFC. Also at 2-weeks in the ventral 
mPFC, we observe a decrease in all intracellular NMDAR subunits. This indicates that 
there is less net expression of NMDA receptors and increased contribution of AMPA 
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receptors in the ventral mPFC. Subunit changes that are observed at 3 weeks post 
withdrawal affect sensitized animals similarly. This occurs regardless of acute drug 
exposure, which may possibly indicate an enhancement of long-term potentiation (LTP). 
This is unsurprising, as an enhancement of LTP is reported to occur in the mPFC of 
sensitized animals after only 3 days of drug abstinence. These changes are restricted to 
the extracellular fraction of the ventral mPFC, and included sensitization-specific subunit 
increase for the NR2B and GluR2 subunits. For these subunits, sensitized animals acutely 
exposed display elevated external levels when compared to previously cocaine naïve 
animals acutely exposed on test day. 
 
In comparing independently-gathered results to published studies, seemingly 
disparate studies can fit together in a cohesive manner. An example of these in observed 
for our prefrontal iGluR and SAPAP studies. In sensitized animals, normal function can 
be restored to the glutamatergically-overactive dorsal striatum by the introduction of 
AMPA antagonist [204]. This would fit our findings for the SAPAP studies, as the 
NMDA/AMPA receptor ratio is vital to proper synaptic functioning [205]. This lack of 
counter-input to AMPA receptors would be explained by decreased SAPAP levels, 
perhaps because receptors that are not anchored to the PSD tend to be removed from the 
PSD [206]. Yet, this may also occur because these NMDA receptors are not clustered 
together, presently a functionally inefficient arrangement that impairs functions. In 
response to cocaine self-administration, the finding that all SAPAPs in the dorsal mPFC 
and dendritic SAPAP3 in the ventral mPFC are altered may reflect the unequal roles of 
these regions in the sensitization process. In cocaine-naïve animals such as the test 
animals, the dorsal mPFC is implicated in the effects of acute effects of cocaine exposure, 
with effects developing later in the ventral mPFC of chronically-exposed animals. 
Although we only examined protein changes, sensitized animals may experience mis-
regulation at a deeper level. Our results here have been partially confirmed by other 
researchers with the discovery that repeated cocaine exposure is found to increase 
prefrontal GluR2 mRNA after 3 weeks of abstinence [207]. In agreement with a wider 
body a literature, this study also shows that in response to repeated cocaine mGluR5 
levels are altered [207]. These same alterations may even extend beyond the context of 
drug use and addiction, as similar changes in SAPAPs, AMPARs, NMDARs, and 
mGluR5 are implicated in neurodevelopmental disorders that cause social dysfunction 
[208]. 
 
Suggestions for future self-administration experiments include using faster 
infusion pumps, and to sensitize animals in the operant testing environment. For future 
experiments involving the study of SAPAPs, a detailed account of location specific 
changes in the regions examined, as various cell types/layers differ in their mRNA 
SAPAP composition [172], and mechanisms regulating their expression patterns in 
cocaine naïve versus sensitized animals will help to uncover the exact purpose of these 
functionally mysterious family of proteins and how they are affected by cocaine 
sensitization. Although we suggest that SAPAP depletion could be responsible for 
compulsive symptoms, we have not tested for compulsivity in sensitized animals. 
Unexpectedly, sensitized rats lesioned with ibotenic acid in the mPFC, while still 
displaying locomotor sensitization, also displayed increased grooming behavior [156], 
 59 
possibly implicating both reduced prefrontal function in this particular compulsive 
behavior. Although it has been observed that a small number of our sensitized animals 
display a “bald” area on their snout, a simple visual survey of sensitized animals could 
yield quantitative data on frequency of bald areas, and if they are linked to compulsive 
grooming. While functional properties of glutamate receptors in the mPFC were not 
investigated in our studies, much is known about how these changes influence receptor 
function. Along with experiments planned to experimentally alter SAPAP levels, these 
receptors may deserve close attention, especially considering that the activity of NMDA 
receptors are regulated through phosphorylation by SAPAPs and that mGluRs, while not 
directly altering synaptic current, contribute greatly to the responses of iGluRs. 
Moreover, both classes of receptor are vital to the progression of research involving 
SAPAPs. Not only are SAPAPs necessary to link NMDARs to the underlying 
cytoskeleton [85], but recent studies have implicated both SAPAP3 and mGluR5 as 
prime mediators in synaptic silencing [141]. SAPAP3 has also been implicated in 
endocannabinoid-related synaptic plasticity [209].  
 
While studied separately for the sake of simplicity, the changes we report all 
occur in concert in response to cocaine. Considering this, there is no reason to assume 
that our self-administration subject animal that displayed the greatest preference for drug 
and greatest resistance to extinction also would not have also been found to have the 
lowest levels of SAPAP3 and the most drastically altered iGluRs. Evidence of this 
impingement may be found in our preliminary experiments. For one such experiment, we 
selected animals that were age-matched cage mates. These rats were sensitized under 
identical conditions. Rats were randomly chosen to either be probed for SAPAP or iGluR 
changes after a 3-week abstinence period. The animals chosen for the SAPAP studies 
displayed a decrease in prefrontal SAPAP3 levels. Additionally, those chosen for iGluR 
studies displayed an increase in surface NR1 subunit levels. Both of these findings 
correspond directly with cocaine exposure (Figure 5-1). Interactions between SAPAPs 
and iGluRs may also in part explain the enhanced acquisition of reinforcement training in 
sensitized animals. As a possible mechanistic explanation for our data, if SAPAPs are 
absent from the PSD, several self-perpetuating changes may occur. Firstly, the 
degradation or inactivation of SAPAP results in increased dendritic outgrowth similar to 
that observed in MSNs in the nucleus accumbens. If SAPAPs proteins are reduced, this 
would explain the increased dopaminergic tone in the medial prefrontal cortex. This 
increase in dopamine would account for the increased glutamate release not only in this 
region, but also in areas where these neurons project (including the nucleus accumbens). 
In addition, reciprocating glutamatergic release onto the Nacc has an increased effect, as 
SAPAP degradation results in increased areas of input due to increased dendrites. 
Combined with the consideration that SAPAPs serve to activate NMDA receptors 
through their guanylate kinase domains, absence of these molecules may explain the 
greater contribution of excitatory currents in published studies. This may also help to our 
results of increased NMDA receptors, as these cortical neurons may compensate for lack 
of NMDA receptor input by expressing more NMDA receptors. Perhaps due to this 
putative increased contribution of excitatory AMPA currents, cortical neurons may be 
hypo-functional, a possible cause of increased operant responding in sensitized animals 
due to decreased executive function 
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Figure 5-1. Possible Correlation Between SAPAP and AMPA/NMDA Receptor 
Studies. 
In rats sensitized at exactly the same time in the exactly same manner, animals selected 
for SAPAP studies displayed a decrease in prefrontal SAPAP3 levels, while those chosen 
for iGluR studies displayed an increase in surface NR1 subunit levels, both which 
corresponding directly with cocaine exposure. Note that “*” indicates a significant 
change from yoked animals, and “+” indicates a significant change from acutely exposed 
saline animals. 
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